data_2l67_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l67 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.608 ' HG ' HG12 ' A' ' 52' ' ' ILE . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.608 HG12 ' HG ' ' A' ' 39' ' ' SER . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.594 ' HG1' ' H ' ' A' ' 77' ' ' GLU . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.594 ' H ' ' HG1' ' A' ' 73' ' ' THR 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.686 ' HG1' HD21 ' A' ' 111' ' ' ASN . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.686 HD21 ' HG1' ' A' ' 102' ' ' THR . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.499 ' HG ' ' H ' ' A' ' 125' ' ' LYS . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HG ' ' A' ' 124' ' ' SER . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.499 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.461 HD21 HE21 ' A' ' 12' ' ' GLN . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.461 HE21 HD21 ' A' ' 9' ' ' LEU . 3.2 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.534 ' HG1' HG23 ' A' ' 58' ' ' VAL . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' HG1' ' A' ' 53' ' ' THR . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HZ2' ' HG1' ' A' ' 51' ' ' THR . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.413 ' HG1' ' HZ2' ' A' ' 49' ' ' LYS . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' HA3' ' HG1' ' A' ' 75' ' ' THR . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.481 ' HG1' ' HA3' ' A' ' 23' ' ' GLY . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.589 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.474 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.489 ' HG1' ' HG3' ' A' ' 60' ' ' GLN . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' ' HG1' ' A' ' 51' ' ' THR . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.56 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.608 ' HG ' HG12 ' A' ' 52' ' ' ILE . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.608 HG12 ' HG ' ' A' ' 39' ' ' SER . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.463 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.594 ' HG1' ' H ' ' A' ' 77' ' ' GLU . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.594 ' H ' ' HG1' ' A' ' 73' ' ' THR 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.686 ' HG1' HD21 ' A' ' 111' ' ' ASN . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.686 HD21 ' HG1' ' A' ' 102' ' ' THR . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.499 ' HG ' ' H ' ' A' ' 125' ' ' LYS . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HG ' ' A' ' 124' ' ' SER . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.499 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD21 HE21 ' A' ' 12' ' ' GLN . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.461 HE21 HD21 ' A' ' 9' ' ' LEU . 3.2 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.534 ' HG1' HG23 ' A' ' 58' ' ' VAL . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' HG1' ' A' ' 53' ' ' THR . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HZ2' ' HG1' ' A' ' 51' ' ' THR . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.413 ' HG1' ' HZ2' ' A' ' 49' ' ' LYS . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' HA3' ' HG1' ' A' ' 75' ' ' THR . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.481 ' HG1' ' HA3' ' A' ' 23' ' ' GLY . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.589 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.474 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.474 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' HA ' ' HG ' ' A' ' 124' ' ' SER . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.489 ' HG1' ' HG3' ' A' ' 60' ' ' GLN . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.489 ' HG3' ' HG1' ' A' ' 51' ' ' THR . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.56 ' HG ' ' HA ' ' A' ' 9' ' ' LEU . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 74' ' ' MET . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 24' ' ' LEU . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 100' ' ' SER . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 74' ' ' MET . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 24' ' ' LEU . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 100' ' ' SER . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 74' ' ' MET . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 24' ' ' LEU . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 HE21 ' A' ' 12' ' ' GLN . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.413 HE21 HD21 ' A' ' 9' ' ' LEU . 3.2 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.427 HE22 ' HG2' ' A' ' 122' ' ' ARG . 1.8 mm-40 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HG2' HE22 ' A' ' 12' ' ' GLN . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 100' ' ' SER . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 CA--C 1.547 0.838 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.01 -7.48 56.93 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 117.798 2.518 . . . . 0.0 117.798 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.1 p -68.43 112.49 5.3 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.652 2.023 . . . . 0.0 112.449 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.38 161.03 13.47 Favored Glycine 0 CA--C 1.543 1.836 0 CA-C-O 122.256 0.92 . . . . 0.0 114.264 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -83.55 133.92 34.85 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.573 -0.814 . . . . 0.0 109.779 168.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -130.73 100.14 5.19 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -79.36 135.39 36.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.266 0.555 . . . . 0.0 110.765 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -73.86 132.52 42.61 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.166 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -103.13 -65.57 0.99 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.732 171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -128.71 129.29 45.56 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.58 119.53 36.46 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.609 0.719 . . . . 0.0 109.442 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -80.3 119.74 23.44 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.65 64.32 0.8 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -76.39 -62.34 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 0.0 111.052 164.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.41 -34.3 72.36 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.87 86.59 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -65.88 -50.59 63.94 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.7 mmt -63.61 -41.83 98.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -63.43 -41.7 98.69 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 166.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 -37.72 87.52 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -65.5 -45.94 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.305 0.957 . . . . 0.0 113.326 168.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.42 66.68 0.09 OUTLIER Glycine 0 CA--C 1.541 1.712 0 C-N-CA 123.759 0.695 . . . . 0.0 113.385 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 74' ' ' MET . 21.8 mt -117.84 150.43 47.1 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.527 0.731 . . . . 0.0 111.006 172.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -70.05 173.98 10.44 Favored 'Trans proline' 0 CA--C 1.562 1.889 0 C-N-CA 123.024 2.483 . . . . 0.0 114.313 171.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -85.87 54.07 3.0 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 122.438 1.113 . . . . 0.0 111.624 166.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -136.52 -67.49 0.51 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.5 mt -62.6 -30.71 71.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 169.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 83.2 mt -59.36 -50.21 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 119.766 1.167 . . . . 0.0 111.824 164.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -64.51 -19.25 65.48 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 117.819 2.526 . . . . 0.0 117.819 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -64.42 -59.58 4.18 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 120.335 1.425 . . . . 0.0 112.694 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.11 41.05 2.26 Favored Glycine 0 CA--C 1.545 1.955 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.264 23.3 pttm -64.83 -58.71 5.49 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 119.529 1.665 . . . . 0.0 113.465 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -140.12 74.7 1.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 154.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.2 mt -130.59 115.94 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -65.73 129.87 41.3 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.51 139.13 15.42 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.792 -177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.8 t -89.41 116.99 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.7 t -88.0 100.89 13.26 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -90.42 98.23 11.65 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.9 mt -97.7 130.42 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.28 101.33 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -85.74 112.22 20.86 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -114.1 74.45 0.87 Allowed 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.19 -112.58 4.94 Favored Glycine 0 CA--C 1.545 1.908 0 C-N-CA 123.083 0.373 . . . . 0.0 113.188 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -81.26 -26.76 35.52 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -83.84 107.91 16.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 121.003 1.729 . . . . 0.0 110.256 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.46 147.5 25.8 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.893 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -136.61 156.25 48.81 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 158.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.49 124.45 11.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.858 -0.526 . . . . 0.0 110.345 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.9 m -114.4 96.35 5.73 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.8 mt -86.55 125.66 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.7 p -127.78 71.38 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.061 0.545 . . . . 0.0 109.802 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.08 91.84 5.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.814 -0.554 . . . . 0.0 111.36 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.0 -107.13 3.47 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.6 m -135.17 70.8 1.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.507 0.67 . . . . 0.0 109.709 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 99.93 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.98 105.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.6 mt -111.23 101.06 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.85 123.08 42.87 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -122.09 157.2 31.97 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.109 0.964 . . . . 0.0 110.52 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -148.71 121.46 8.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.77 155.7 46.22 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.523 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.0 m -119.34 129.74 55.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 168.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.36 128.68 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 123.307 0.643 . . . . 0.0 111.792 -174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.35 23.17 71.55 Favored Glycine 0 CA--C 1.555 2.563 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -165.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -141.5 141.7 33.6 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.647 1.223 . . . . 0.0 107.958 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.13 110.3 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.289 0.636 . . . . 0.0 110.701 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.0 m -128.03 129.38 46.59 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.981 -166.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.58 120.09 25.09 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.71 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -118.18 130.3 56.01 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.47 93.58 5.42 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.34 0.59 . . . . 0.0 109.894 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 80.2 p -87.43 166.98 14.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.406 ' HB3' HD11 ' A' ' 24' ' ' LEU . 26.3 mmt -48.63 -58.49 4.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -95.29 -43.95 7.81 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.785 0.834 . . . . 0.0 113.164 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.05 105.77 2.1 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 119.445 1.021 . . . . 0.0 112.452 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.59 -47.99 83.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -167.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -144.23 100.09 3.49 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 166.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -105.71 121.4 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 C-N-CA 124.307 1.043 . . . . 0.0 110.691 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.38 123.52 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.869 0.868 . . . . 0.0 111.68 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.2 t -152.78 137.74 17.2 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.026 168.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.53 127.46 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.55 111.65 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -94.1 127.63 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.63 0.729 . . . . 0.0 110.296 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.9 tp -100.89 125.34 47.43 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.618 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.77 115.68 28.33 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.135 167.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.16 -117.12 8.19 Favored Glycine 0 CA--C 1.545 1.927 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.491 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.95 12.17 2.88 Favored 'General case' 0 CA--C 1.574 1.871 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 165.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -140.19 33.85 1.91 Allowed 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -156.25 103.85 2.2 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 119.436 1.016 . . . . 0.0 108.565 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.8 mt -88.67 132.96 34.36 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.35 0.66 . . . . 0.0 109.548 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.27 109.2 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 -170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -147.42 166.02 28.45 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.523 1.154 . . . . 0.0 110.743 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -145.88 123.09 11.53 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -81.5 -83.5 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.155 -172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -105.82 -81.87 0.54 Allowed 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.36 65.06 1.15 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 119.163 0.892 . . . . 0.0 109.005 160.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.5 mt -142.04 100.87 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 103.814 -2.662 . . . . 0.0 103.814 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.61 99.77 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.26 0.624 . . . . 0.0 109.992 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.6 t -99.85 108.28 20.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.565 0.746 . . . . 0.0 109.193 -174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -114.79 104.95 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 105.909 -1.885 . . . . 0.0 105.909 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.5 m -101.86 88.22 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.23 121.99 42.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.307 0.643 . . . . 0.0 109.464 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.39 134.82 36.07 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.918 175.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -126.05 66.58 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.903 0.881 . . . . 0.0 109.046 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.97 -91.08 1.3 Allowed Glycine 0 N--CA 1.485 1.904 0 O-C-N 121.972 -0.455 . . . . 0.0 113.05 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.63 -37.07 13.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 164.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.5 mm -82.19 105.47 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 119.335 0.971 . . . . 0.0 109.464 -165.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -82.81 109.83 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.8 m -105.11 97.68 7.5 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -92.78 98.91 11.7 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.4 m -96.4 95.1 7.82 Favored 'General case' 0 CA--C 1.557 1.212 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.3 ttm -106.74 103.88 13.42 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -168.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.0 m -105.02 122.2 45.37 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -168.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -79.13 -61.2 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.474 0.71 . . . . 0.0 111.099 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.24 -82.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.441 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 173.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.72 -34.1 34.74 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 168.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.34 126.66 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.0 t -110.76 104.26 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.63 92.3 9.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.156 0.582 . . . . 0.0 110.128 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -99.91 110.95 23.28 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -92.11 128.85 38.11 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 169.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.86 100.17 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -123.59 107.26 11.33 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.522 0.677 . . . . 0.0 110.883 -168.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -82.75 141.13 32.61 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.355 1.062 . . . . 0.0 111.087 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -70.95 106.29 3.59 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.568 0.747 . . . . 0.0 111.888 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 122.641 1.21 . . . . 0.0 111.371 176.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.7 -9.83 58.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 117.822 2.527 . . . . 0.0 117.822 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -73.94 129.52 38.05 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.711 2.05 . . . . 0.0 112.833 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.04 163.93 11.25 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 121.877 0.709 . . . . 0.0 112.997 -174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -90.33 132.26 35.67 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.989 0.516 . . . . 0.0 110.313 167.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -129.69 99.71 5.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -77.4 131.48 38.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.874 0.869 . . . . 0.0 110.701 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.8 tp -64.49 125.99 26.43 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.565 0.698 . . . . 0.0 112.1 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -107.71 -47.57 3.58 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.601 1.16 . . . . 0.0 111.609 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.7 m -144.07 106.24 4.37 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 119.064 0.847 . . . . 0.0 109.395 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -95.2 108.97 21.12 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.798 0.839 . . . . 0.0 109.452 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -97.45 118.79 34.73 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 77.6 m-20 66.44 63.14 0.53 Allowed 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -175.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -88.01 -50.47 6.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 118.468 -0.777 . . . . 0.0 111.433 167.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -60.75 -44.16 97.04 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.53 95.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 172.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.85 -50.44 42.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.0 mmt -68.02 -36.54 80.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -72.35 -34.46 68.02 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.15 99.65 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.8 pt -64.31 -41.21 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 169.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.2 61.77 0.11 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 118.846 0.748 . . . . 0.0 114.594 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.71 150.88 44.73 Favored Pre-proline 0 CA--C 1.572 1.814 0 C-N-CA 123.808 0.843 . . . . 0.0 109.346 169.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.36 162.42 38.82 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.883 2.389 . . . . 0.0 113.636 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -84.42 54.04 2.86 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.633 1.206 . . . . 0.0 112.202 171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.18 -57.11 0.41 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 126.048 1.739 . . . . 0.0 108.275 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.21 -40.82 94.67 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.8 mt -51.84 -45.45 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 C-N-CA 124.151 0.98 . . . . 0.0 113.348 166.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -62.35 -32.43 73.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -62.72 -51.21 68.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 166.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.8 -23.06 78.58 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 118.784 2.273 . . . . 0.0 118.784 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -66.59 -48.19 70.33 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 119.446 1.623 . . . . 0.0 114.287 171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -76.35 -44.59 35.87 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.101 0.96 . . . . 0.0 113.415 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mt -85.23 101.84 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 123.41 27.97 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.205 0.602 . . . . 0.0 110.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.53 153.15 21.18 Favored Glycine 0 CA--C 1.54 1.607 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 -165.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -87.99 119.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.6 t -92.8 97.58 10.86 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -94.65 91.6 6.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.9 mt -89.62 131.81 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.7 105.98 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -85.82 141.93 29.28 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.386 0.612 . . . . 0.0 111.038 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -140.92 77.82 1.62 Allowed 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.81 -112.33 4.04 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 122.988 0.328 . . . . 0.0 112.373 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.83 -22.29 27.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 166.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -89.1 99.58 12.54 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 120.927 1.694 . . . . 0.0 110.091 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -98.11 150.22 21.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.994 0.902 . . . . 0.0 110.543 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -139.16 157.22 46.32 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.151 167.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -150.92 130.25 12.83 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.65 -0.656 . . . . 0.0 111.335 169.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 m -106.17 110.2 22.38 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.32 118.22 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.5 p -117.06 77.28 1.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.254 . . -83.18 -104.47 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.266 0.626 . . . . 0.0 111.358 -173.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.08 -97.63 0.54 Allowed Glycine 0 N--CA 1.48 1.599 0 C-N-CA 123.456 0.55 . . . . 0.0 112.384 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.3 m -112.75 69.52 0.69 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 156.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -148.22 95.33 2.45 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -171.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -102.05 92.78 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.3 mt -115.02 99.63 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -170.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -102.83 120.23 40.23 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.423 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -108.91 150.69 27.33 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.3 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -136.51 111.12 8.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -117.19 128.41 55.07 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.53 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -99.02 118.82 36.66 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.19 134.51 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 123.265 0.626 . . . . 0.0 112.685 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.52 4.04 Favored Glycine 0 CA--C 1.552 2.396 0 N-CA-C 117.224 1.649 . . . . 0.0 117.224 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.54 162.13 13.3 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.501 1.12 . . . . 0.0 110.909 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.62 108.02 10.52 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -138.15 149.08 45.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.92 0.866 . . . . 0.0 111.634 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -64.39 127.05 29.8 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.6 mt -115.77 108.7 16.67 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 164.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.78 106.62 9.72 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 p -85.85 161.98 18.84 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.107 0.956 . . . . 0.0 112.433 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.5 mmt -54.66 -35.15 63.2 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.0 t -149.73 120.71 7.68 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.43 -130.82 2.19 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -160.97 84.15 0.67 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt 45.72 76.21 0.1 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 167.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.41 110.19 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 C-N-CA 123.077 0.551 . . . . 0.0 110.82 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -79.75 115.12 19.17 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.56 0.695 . . . . 0.0 110.662 173.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -147.42 143.34 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.842 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -75.61 131.95 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.262 0.625 . . . . 0.0 109.657 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -113.28 107.81 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -93.81 122.58 36.43 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -78.75 122.95 26.67 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.485 0.66 . . . . 0.0 110.319 174.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -100.95 115.08 29.59 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.186 170.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.19 -114.04 5.53 Favored Glycine 0 CA--C 1.546 2.009 0 CA-C-N 114.275 -1.33 . . . . 0.0 113.502 -176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -134.82 -12.84 2.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 -135.53 34.98 2.95 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -156.91 111.39 2.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.094 -1.004 . . . . 0.0 108.659 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.4 mt -106.77 141.74 37.53 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.656 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.39 124.04 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.752 0.821 . . . . 0.0 109.348 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -157.14 116.89 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.952 0.882 . . . . 0.0 109.879 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.5 t -100.57 127.88 46.81 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 164.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -78.13 -72.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.277 -174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -136.9 -80.96 0.38 Allowed 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -89.2 -33.41 17.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.6 mt -78.14 133.2 30.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 C-N-CA 124.454 1.102 . . . . 0.0 108.89 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -88.56 148.33 24.15 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.425 0.69 . . . . 0.0 110.158 167.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -149.68 126.85 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.943 0.497 . . . . 0.0 110.46 172.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -130.51 114.81 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 m -102.79 89.61 3.54 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -105.72 121.12 43.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.52 114.68 25.4 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -105.19 87.53 2.65 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.93 -90.01 1.65 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-O 119.857 -0.413 . . . . 0.0 113.207 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -136.81 49.83 2.04 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 122.964 0.506 . . . . 0.0 110.85 163.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.45 116.04 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 30.5 mm -76.46 112.78 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 m -106.14 97.91 7.66 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.13 97.44 9.55 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -96.37 104.48 16.45 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtm -107.32 106.92 17.59 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.5 m -95.71 121.65 37.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.0 tp -130.94 99.85 5.05 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.9 -98.46 1.19 Allowed Glycine 0 N--CA 1.483 1.77 0 CA-C-N 116.462 -0.335 . . . . 0.0 112.477 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -133.36 58.29 1.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 162.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.9 mt -130.66 106.69 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.11 95.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -84.86 100.09 11.35 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.982 0.513 . . . . 0.0 110.172 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -98.95 102.99 14.91 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.294 1.045 . . . . 0.0 108.916 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -86.58 95.53 9.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.811 -1.541 . . . . 0.0 107.205 172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.7 mt -98.4 100.51 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -170.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.1 m -115.93 99.23 7.13 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.61 0.719 . . . . 0.0 110.131 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -76.36 141.27 41.56 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.101 0.96 . . . . 0.0 111.833 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -73.86 117.83 16.1 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.41 0.684 . . . . 0.0 111.692 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.0 mm . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 -178.764 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.549 0.932 0 CA-C-O 121.134 0.493 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -74.76 -3.07 29.43 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.8 p -73.04 114.31 11.05 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 121.343 1.883 . . . . 0.0 111.718 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.44 156.76 13.64 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-O 122.198 0.888 . . . . 0.0 112.929 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -100.78 101.78 12.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -105.26 109.42 21.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -166.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -83.44 127.47 33.73 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.82 126.46 27.7 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.698 0.761 . . . . 0.0 112.092 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -108.81 -50.96 2.94 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.569 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.6 t -142.26 106.2 4.73 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 119.485 1.039 . . . . 0.0 109.255 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -95.46 123.38 38.97 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.248 0.619 . . . . 0.0 109.825 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 38.2 tt0 -75.83 -60.4 2.33 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -128.44 74.43 1.56 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.106 0.866 . . . . 0.0 109.383 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -75.07 -53.29 9.14 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.807 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -62.18 -47.88 82.53 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.81 92.66 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 174.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -67.92 -51.42 47.97 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -65.29 -40.25 93.6 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -68.73 -37.05 79.17 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 170.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.14 89.62 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.3 pt -64.19 -39.27 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 172.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.62 70.62 0.14 Allowed Glycine 0 N--CA 1.48 1.63 0 CA-C-N 118.745 0.702 . . . . 0.0 112.619 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.9 mt -132.88 145.27 56.37 Favored Pre-proline 0 CA--C 1.568 1.652 0 C-N-CA 123.277 0.631 . . . . 0.0 110.851 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.97 176.09 8.87 Favored 'Trans proline' 0 CA--C 1.56 1.791 0 C-N-CA 123.332 2.688 . . . . 0.0 114.428 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -83.47 51.39 1.98 Allowed 'General case' 0 CA--C 1.576 1.973 0 CA-C-O 122.354 1.074 . . . . 0.0 112.219 167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -142.29 -62.36 0.44 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.763 1.625 . . . . 0.0 107.284 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.93 -32.82 72.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 166.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.71 -57.51 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-N 119.247 0.93 . . . . 0.0 111.048 165.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.74 -21.22 62.74 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 118.282 2.697 . . . . 0.0 118.282 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -67.13 -53.85 26.84 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.18 30.34 10.12 Favored Glycine 0 CA--C 1.55 2.241 0 N-CA-C 118.224 2.05 . . . . 0.0 118.224 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -62.06 1.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.426 1.613 . . . . 0.0 112.4 171.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -86.15 -32.54 21.22 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.79 107.82 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -90.62 121.47 32.57 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.927 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 155.47 26.87 Favored Glycine 0 CA--C 1.539 1.562 0 N-CA-C 116.068 1.187 . . . . 0.0 116.068 -168.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 66.4 t -95.51 111.8 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 t -83.94 99.37 10.34 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 169.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -95.15 93.21 7.2 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.8 mt -91.27 121.12 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.76 101.23 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -85.46 108.78 18.05 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -84.24 -67.16 0.82 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.23 0.612 . . . . 0.0 110.545 178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.59 87.66 0.07 OUTLIER Glycine 0 N--CA 1.477 1.398 0 N-CA-C 107.262 -2.335 . . . . 0.0 107.262 174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.366 57.5 mttp 67.24 -18.97 0.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 118.153 2.649 . . . . 0.0 118.153 -164.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -95.44 119.57 34.18 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 120.888 1.676 . . . . 0.0 108.212 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -116.78 152.89 33.44 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 122.182 0.991 . . . . 0.0 110.825 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -153.99 150.75 28.61 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.734 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -151.01 152.89 34.14 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.373 0.669 . . . . 0.0 111.645 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.0 m -133.06 120.15 20.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.95 113.24 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 m -108.44 90.98 3.46 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . 0.261 . . -91.63 -120.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.387 0.675 . . . . 0.0 110.466 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.05 -95.98 0.13 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-N 118.766 0.712 . . . . 0.0 112.781 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.2 t -106.83 77.71 1.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 158.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -151.33 107.87 3.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -127.2 94.76 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -105.67 100.98 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -90.24 120.31 31.29 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.62 0.724 . . . . 0.0 109.976 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -122.83 137.47 54.92 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.95 -170.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -139.5 125.94 20.34 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.34 141.07 33.88 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.834 0.454 . . . . 0.0 110.888 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -114.86 122.64 46.95 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.0 m -72.85 137.6 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -168.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.74 6.78 85.52 Favored Glycine 0 CA--C 1.556 2.638 0 N-CA-C 118.779 2.272 . . . . 0.0 118.779 -165.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.5 144.1 50.21 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.983 1.392 . . . . 0.0 107.895 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -74.8 97.31 3.25 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.21 0.529 . . . . 0.0 111.259 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.14 141.53 44.52 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.59 0.71 . . . . 0.0 110.881 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.11 118.7 21.32 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.969 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -109.91 129.08 55.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -76.05 103.16 5.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.11 -0.369 . . . . 0.0 110.027 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 82.4 p -80.87 150.76 28.96 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.764 0.792 . . . . 0.0 111.596 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.44 63.98 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.8 t -141.37 103.68 4.46 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.04 -142.21 7.33 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -162.05 83.62 0.57 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.493 0.317 . . . . 0.0 110.33 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.25 79.32 0.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.885 1.274 . . . . 0.0 114.209 164.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.65 111.68 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.025 0.53 . . . . 0.0 111.256 -160.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -76.51 104.49 7.05 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.287 0.565 . . . . 0.0 110.896 178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.7 t -139.63 136.1 33.98 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.203 -170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.7 t -79.3 120.13 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 t -105.04 103.75 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -89.23 128.93 35.87 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.886 0.766 . . . . 0.0 110.25 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -87.2 120.12 28.14 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.482 175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -101.3 113.89 27.36 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.211 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.06 -112.16 4.52 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 114.19 -1.368 . . . . 0.0 113.4 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -137.61 -3.99 1.85 Allowed 'General case' 0 CA--C 1.573 1.858 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -135.87 35.55 2.86 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 -175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -154.81 126.06 7.29 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 108.626 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 36.9 mt -116.93 132.44 56.7 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.98 119.24 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.5 t -147.84 157.0 43.32 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.84 0.856 . . . . 0.0 110.379 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -140.5 124.78 17.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -150.95 131.97 14.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.066 0.546 . . . . 0.0 110.76 -172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 57.58 44.27 21.23 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 4.0 t30 50.7 50.57 18.69 Favored 'General case' 0 CA--C 1.572 1.794 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 mt -138.63 116.67 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 -177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -77.78 102.8 7.36 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 166.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 t -111.02 105.43 14.19 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.97 112.81 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.5 m -101.79 91.09 4.24 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -101.59 122.88 44.66 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.01 116.22 20.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.71 64.86 0.63 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.159 0.504 . . . . 0.0 110.37 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.29 72.69 0.61 Allowed Glycine 0 N--CA 1.486 1.98 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.292 15.1 m-20 68.47 -22.47 0.13 Allowed 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 117.626 2.454 . . . . 0.0 117.626 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.1 mt -99.49 95.62 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.4 tt -86.1 117.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.549 0.74 . . . . 0.0 109.429 -175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 62.3 m -108.91 106.92 17.1 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -100.88 99.79 10.34 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.7 m -90.58 104.85 17.39 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 114.364 -1.289 . . . . 0.0 107.548 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 84.1 mtp -107.16 101.39 10.79 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.5 m -106.45 112.61 25.7 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 tp -69.44 -59.8 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.796 0.839 . . . . 0.0 112.33 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -154.78 -81.24 0.03 OUTLIER Glycine 0 N--CA 1.477 1.416 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -79.45 -32.62 42.72 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 165.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.0 mt -84.24 120.05 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 119.453 1.024 . . . . 0.0 108.506 -169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.95 99.37 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -89.25 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.107 0.963 . . . . 0.0 109.371 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 27.4 ttpp -111.69 103.49 11.79 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -88.33 109.16 19.75 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.573 0.749 . . . . 0.0 109.262 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 mt -102.11 105.06 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.6 m -117.67 104.14 10.71 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.49 0.662 . . . . 0.0 110.408 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -82.38 134.22 35.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.745 0.818 . . . . 0.0 109.987 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -68.98 101.87 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.432 0.693 . . . . 0.0 111.85 -172.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . 0.273 42.1 mm . . . . . 0 N--CA 1.494 1.732 0 C-N-CA 124.956 1.303 . . . . 0.0 109.767 -169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 121.669 0.747 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 53.51 47.97 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 t -142.52 101.93 3.97 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.6 -148.81 10.45 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-O 122.328 0.96 . . . . 0.0 111.962 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 117.05 5.3 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -127.24 102.52 6.96 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -158.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -82.26 142.76 31.83 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.517 0.675 . . . . 0.0 111.532 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.8 tp -72.53 119.15 16.35 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.31 -173.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -90.37 -65.41 1.02 Allowed 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.658 -176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.0 t -135.37 128.93 32.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.816 0.735 . . . . 0.0 110.105 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -99.11 129.08 45.35 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -76.94 -61.93 1.82 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.027 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -136.82 75.05 1.51 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -79.86 -49.14 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.255 -0.903 . . . . 0.0 112.501 164.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.93 -43.53 98.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.51 -47.72 62.9 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -64.74 -49.18 71.82 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mmt -64.09 -37.65 88.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -62.79 -42.73 99.83 Favored 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 166.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.4 82.93 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -63.58 -40.84 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.82 68.77 0.23 Allowed Glycine 0 CA--C 1.542 1.763 0 CA-C-N 118.715 0.689 . . . . 0.0 113.369 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.3 mt -125.76 154.83 73.28 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 123.757 0.823 . . . . 0.0 111.161 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.49 159.49 48.96 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.188 2.592 . . . . 0.0 113.999 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.84 -19.76 64.41 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 117.396 2.369 . . . . 0.0 117.396 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.74 -55.79 23.49 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.729 1.15 . . . . 0.0 113.641 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.24 -33.01 72.62 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -62.08 -51.27 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-N 119.356 0.98 . . . . 0.0 111.578 167.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -93.56 54.38 2.02 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 121.955 0.883 . . . . 0.0 112.282 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.13 -53.82 0.26 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.176 1.39 . . . . 0.0 108.436 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.44 -27.36 70.69 Favored Glycine 0 CA--C 1.547 2.078 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 168.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.41 -48.66 18.69 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 171.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -84.54 -46.92 11.1 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.09 0.956 . . . . 0.0 113.389 171.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -84.34 117.12 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.056 0.843 . . . . 0.0 108.906 -165.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -88.86 150.45 22.88 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.907 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.83 173.18 27.12 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-O 122.713 1.174 . . . . 0.0 113.634 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -95.84 124.46 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 114.214 -0.993 . . . . 0.0 109.046 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.7 m -96.25 104.82 16.8 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.767 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -98.42 116.95 31.75 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.8 mt -118.32 129.56 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -167.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -125.17 115.15 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -95.05 113.11 24.77 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 163.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -107.61 72.25 0.85 Allowed 'General case' 0 CA--C 1.561 1.373 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.65 -111.46 3.76 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.138 0.399 . . . . 0.0 112.772 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -81.1 -30.06 34.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -82.96 109.3 16.94 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 119.292 0.951 . . . . 0.0 109.915 -170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.93 154.56 20.89 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.163 0.982 . . . . 0.0 112.583 -168.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.87 153.42 40.84 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.286 156.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -150.13 120.05 7.14 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 t -93.19 158.51 15.72 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 120.939 0.399 . . . . 0.0 110.61 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -139.95 122.37 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.5 m -127.24 125.09 40.36 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.45 97.36 1.47 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.74 -104.49 2.29 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.5 t -144.02 74.63 1.43 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.488 0.661 . . . . 0.0 109.231 169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.81 101.66 1.98 Allowed 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.0 96.54 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 177.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.35 96.58 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -168.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -92.5 107.37 19.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -102.7 142.36 33.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.469 0.708 . . . . 0.0 109.928 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -135.74 118.95 16.59 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.8 176.26 8.63 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.938 0.875 . . . . 0.0 112.414 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.8 m -138.11 131.71 30.92 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.0 m -67.68 129.07 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 123.604 0.761 . . . . 0.0 112.257 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.56 29.18 72.86 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 118.091 1.996 . . . . 0.0 118.091 -168.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -152.53 134.88 15.11 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.17 126.82 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.546 0.689 . . . . 0.0 112.512 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -150.91 143.83 24.59 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.728 -176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.55 123.81 21.47 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.86 116.59 31.5 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -76.88 114.51 15.74 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.195 0.598 . . . . 0.0 109.594 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.7 p -76.19 165.21 25.23 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.942 0.877 . . . . 0.0 112.56 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -37.07 80.05 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 176.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.9 p -67.21 -60.7 2.39 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 120.021 1.282 . . . . 0.0 113.22 167.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.35 75.28 0.02 OUTLIER Glycine 0 CA--C 1.539 1.576 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.52 118.49 11.21 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mttp -98.53 86.52 3.61 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.91 114.38 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.344 -151.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 123.12 21.83 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.511 0.672 . . . . 0.0 111.733 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -153.0 141.1 20.39 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.658 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.9 t -86.44 124.2 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.53 118.21 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.74 126.97 43.37 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 tp -91.13 123.22 34.42 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.431 0.634 . . . . 0.0 109.454 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -121.59 128.31 51.83 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.467 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.63 15.02 63.55 Favored Glycine 0 CA--C 1.556 2.596 0 N-CA-C 119.951 2.74 . . . . 0.0 119.951 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.328 6.8 t70 77.42 -18.96 0.46 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -173.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -144.93 44.67 1.35 Allowed 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -156.57 112.91 3.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.029 174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.98 123.5 47.29 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.697 0.799 . . . . 0.0 109.483 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.3 126.67 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.893 0.877 . . . . 0.0 109.353 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 t -158.19 113.32 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.948 0.88 . . . . 0.0 111.417 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 123.96 46.98 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.425 1.09 . . . . 0.0 108.498 170.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.273 0.0 OUTLIER -88.12 -75.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.899 -174.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -96.23 -85.47 0.33 Allowed 'General case' 0 CA--C 1.559 1.293 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 169.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.72 65.25 1.57 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 163.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -140.35 95.97 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -77.62 124.81 28.42 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.609 0.719 . . . . 0.0 110.183 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.0 m -114.71 98.37 6.82 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.7 96.77 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.0 m -96.06 92.12 6.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -108.6 122.01 46.21 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.75 111.02 20.89 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -101.67 77.8 1.78 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.78 -82.67 1.66 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.008 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -113.18 -45.82 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.003 0.921 . . . . 0.0 112.074 165.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.8 118.81 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-N 119.277 0.944 . . . . 0.0 109.108 -167.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.0 tt -94.17 125.57 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.884 0.873 . . . . 0.0 109.932 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.5 m -119.46 110.27 16.72 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -101.14 106.31 17.54 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -94.64 96.5 9.46 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -94.11 108.99 20.79 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.3 m -106.95 113.08 26.35 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.5 tp -71.43 -60.64 2.12 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.042 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.38 -81.08 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.65 -34.66 34.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 167.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.15 121.15 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-N 119.478 1.036 . . . . 0.0 108.273 -171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.89 98.77 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -89.83 96.85 10.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.418 0.687 . . . . 0.0 109.882 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -94.86 100.33 12.23 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.104 0.962 . . . . 0.0 108.579 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 ptp85 -93.6 108.31 20.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.593 0.711 . . . . 0.0 109.841 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.2 mt -95.05 117.8 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -123.58 114.07 19.54 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.479 0.712 . . . . 0.0 109.745 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -72.61 141.6 48.36 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.042 0.937 . . . . 0.0 113.155 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -79.57 130.28 35.24 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.899 0.479 . . . . 0.0 110.531 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -178.558 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.549 0.918 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -72.72 -7.14 49.06 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.5 t -69.81 108.94 4.16 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.997 1.726 . . . . 0.0 112.172 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.3 159.08 14.16 Favored Glycine 0 CA--C 1.543 1.801 0 CA-C-O 122.348 0.971 . . . . 0.0 114.005 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.29 121.67 41.85 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.02 -1.09 . . . . 0.0 109.412 174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -129.57 107.78 9.73 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -79.93 136.27 36.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.602 0.761 . . . . 0.0 110.779 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -65.54 117.51 8.12 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.016 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -85.6 -63.81 1.26 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.066 0.946 . . . . 0.0 111.332 176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.1 t -144.8 123.92 12.88 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.6 pm0 -112.77 142.6 45.21 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.715 0.806 . . . . 0.0 111.056 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.77 -61.49 1.86 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -131.7 73.74 1.55 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 118.806 0.73 . . . . 0.0 109.791 -171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -72.12 -54.16 10.6 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 171.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.77 -47.88 76.55 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.07 94.41 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -66.02 -50.7 63.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -37.0 85.8 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.38 -43.44 85.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.59 -40.18 88.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.5 pt -62.9 -41.51 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 128.79 71.2 0.14 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 119.377 -0.679 . . . . 0.0 112.823 175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 mt -133.15 148.62 69.93 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-N 117.389 0.595 . . . . 0.0 111.066 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.69 156.34 63.78 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.247 2.631 . . . . 0.0 114.151 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.92 -22.4 66.9 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 117.28 2.326 . . . . 0.0 117.28 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.27 -50.16 74.12 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.3 mt -66.6 -35.89 81.28 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.1 mt -65.41 -55.79 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 124.233 1.013 . . . . 0.0 111.839 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -68.87 -18.94 64.22 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.4 -51.61 28.35 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-N 119.852 1.206 . . . . 0.0 113.269 164.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.44 -4.7 84.87 Favored Glycine 0 CA--C 1.552 2.354 0 N-CA-C 120.247 2.859 . . . . 0.0 120.247 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -62.82 -49.53 74.54 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 120.325 2.063 . . . . 0.0 114.581 172.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.37 -35.4 63.53 Favored 'General case' 0 CA--C 1.564 1.509 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.63 117.32 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -92.52 127.72 38.11 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.663 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.74 131.91 11.01 Favored Glycine 0 N--CA 1.478 1.479 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 t -88.52 108.27 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -83.44 107.51 15.98 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.695 0.798 . . . . 0.0 109.303 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.29 83.91 1.85 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -85.13 128.53 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.83 92.1 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.88 114.07 25.1 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.549 0.74 . . . . 0.0 109.279 -177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -127.95 81.37 2.02 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.23 -115.68 6.98 Favored Glycine 0 CA--C 1.546 1.97 0 CA-C-N 116.386 -0.37 . . . . 0.0 112.984 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.34 -19.01 36.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -93.44 113.4 25.55 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.383 1.447 . . . . 0.0 110.072 -171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.86 152.44 23.89 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.946 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -148.78 118.66 7.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 168.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -107.08 128.8 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.85 0.46 . . . . 0.0 110.862 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.1 m -119.53 97.98 5.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mt -100.17 117.6 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -108.54 66.55 0.65 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 122.963 0.505 . . . . 0.0 111.655 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.52 121.84 44.32 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.25 0.62 . . . . 0.0 111.756 -172.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.92 -110.33 3.01 Favored Glycine 0 N--CA 1.483 1.795 0 C-N-CA 122.831 0.253 . . . . 0.0 112.74 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -131.31 71.89 1.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 156.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -149.59 109.35 4.05 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.72 102.41 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 173.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.7 mt -98.25 92.61 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -109.11 108.21 18.8 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -131.57 122.28 25.83 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -103.27 107.62 18.51 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -111.12 166.6 10.94 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.777 0.799 . . . . 0.0 111.157 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.7 m -134.01 133.57 41.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 m -68.5 128.05 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.72 27.74 72.4 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -168.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -140.38 141.03 35.63 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.11 114.48 8.31 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.18 0.592 . . . . 0.0 110.578 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.0 m -143.43 123.06 13.27 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -70.81 141.5 51.35 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 113.512 0.931 . . . . 0.0 113.512 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.6 mt -110.55 122.64 48.25 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.95 108.78 13.8 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.9 p -69.51 154.72 41.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -33.61 38.66 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 164.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.2 m -62.59 -68.16 0.36 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 123.966 0.906 . . . . 0.0 111.252 166.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.4 69.77 0.02 OUTLIER Glycine 0 CA--C 1.54 1.638 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -148.64 119.48 7.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -92.71 93.02 8.24 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.5 p -111.32 111.63 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.341 -162.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.7 120.85 16.08 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.917 0.887 . . . . 0.0 112.38 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -150.69 137.75 19.26 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.144 -173.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.96 120.97 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.28 91.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -92.17 117.67 30.09 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.77 -168.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -76.23 122.25 24.1 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.693 170.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -123.0 129.77 51.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.261 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.04 -97.7 2.35 Favored Glycine 0 N--CA 1.479 1.559 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.953 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -146.71 -48.62 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.524 0.73 . . . . 0.0 112.774 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -138.41 55.35 1.75 Allowed 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.288 1.035 . . . . 0.0 111.701 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -148.85 102.59 3.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 32.9 mt -86.25 129.88 34.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.434 0.693 . . . . 0.0 109.63 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.04 115.17 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -151.05 128.32 11.25 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.336 0.655 . . . . 0.0 110.127 -178.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.63 130.0 55.62 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.124 0.97 . . . . 0.0 108.526 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -145.39 111.42 5.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -170.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.257 60.2 mttp 51.45 54.74 10.54 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -173.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.256 7.3 t-20 46.52 54.9 8.16 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 89.6 mt -136.93 101.98 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.25 98.95 11.61 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.8 m -104.81 110.79 23.28 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.947 -168.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.43 107.78 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.7 m -100.01 86.75 3.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -101.04 131.15 47.07 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.274 0.629 . . . . 0.0 109.593 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -86.49 121.54 29.18 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.075 173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -121.08 76.42 1.22 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.82 -90.91 1.69 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -135.02 60.25 1.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.134 0.492 . . . . 0.0 109.737 158.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 mm -139.03 112.31 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 37.8 mm -81.5 99.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.8 m -92.11 95.41 9.74 Favored 'General case' 0 CA--C 1.557 1.238 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -106.45 97.65 7.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 m -105.05 105.07 14.94 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.4 mtp -107.81 103.58 12.88 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.4 t -113.51 113.01 24.53 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.47 -13.92 60.76 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.15 -87.44 0.14 Allowed Glycine 0 N--CA 1.478 1.462 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.25 -40.97 18.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.5 120.77 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.6 t -105.06 101.27 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -87.82 93.19 9.38 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.242 0.544 . . . . 0.0 109.651 172.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -85.49 138.7 32.05 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.244 0.618 . . . . 0.0 109.816 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -118.78 121.62 40.48 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 171.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.48 103.32 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -117.01 100.29 7.65 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 111.187 -171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.74 152.35 20.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.909 0.883 . . . . 0.0 111.663 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -51.72 152.95 2.61 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 176.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 CA--C 1.548 0.885 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.75 -30.63 70.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 117.301 2.334 . . . . 0.0 117.301 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 138.9 57.8 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-N 120.863 1.665 . . . . 0.0 113.439 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.56 161.62 11.2 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.032 -175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.28 118.77 32.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.96 106.11 14.03 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -75.45 124.53 27.31 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.272 1.029 . . . . 0.0 110.626 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.69 115.37 11.89 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-O 122.135 0.969 . . . . 0.0 111.257 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -95.27 -56.12 2.83 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 114.026 -1.443 . . . . 0.0 112.3 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -128.97 109.37 11.17 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -94.53 102.13 14.06 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -104.09 125.83 50.73 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.361 0.6 . . . . 0.0 109.617 -171.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 m120 66.15 54.86 0.93 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -85.05 -49.27 8.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 112.301 173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.05 -43.21 96.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.39 86.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 170.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.94 -49.92 63.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -37.83 88.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -65.36 -41.38 93.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.49 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -63.82 -41.16 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.45 67.6 0.09 OUTLIER Glycine 0 CA--C 1.541 1.696 0 C-N-CA 123.777 0.703 . . . . 0.0 113.194 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.2 mt -129.21 148.87 70.92 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 123.532 0.733 . . . . 0.0 110.681 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.58 164.97 33.95 Favored 'Trans proline' 0 CA--C 1.56 1.799 0 C-N-CA 123.167 2.578 . . . . 0.0 114.449 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -54.14 -37.37 64.32 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -62.61 -51.98 65.19 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.46 -31.11 71.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.6 mt -69.62 -62.51 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.005 0.922 . . . . 0.0 110.283 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -66.13 -14.93 62.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -64.21 -55.74 19.54 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.227 1.376 . . . . 0.0 112.849 165.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.91 57.73 0.48 Allowed Glycine 0 N--CA 1.484 1.858 0 CA-C-N 119.413 1.006 . . . . 0.0 115.06 172.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.25 20.1 pttp -68.01 -59.86 2.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -130.94 74.07 1.58 Allowed 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 163.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -122.86 103.74 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -97.59 110.45 23.01 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.611 -159.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.0 -126.69 5.13 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.051 -176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.9 t -143.32 124.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.3 m -92.45 104.17 16.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 160.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.1 102.07 13.77 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -172.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mm -76.36 131.3 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -128.16 91.22 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -89.45 113.95 25.37 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -110.37 77.11 1.02 Allowed 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -108.38 2.48 Favored Glycine 0 CA--C 1.546 1.973 0 C-N-CA 123.037 0.351 . . . . 0.0 112.383 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -89.1 -18.7 26.7 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 166.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -88.58 102.73 15.23 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 120.512 1.505 . . . . 0.0 110.164 -171.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.76 151.74 19.86 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.145 0.978 . . . . 0.0 112.552 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 140.87 26.4 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.059 149.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -124.55 110.44 14.46 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.137 0.575 . . . . 0.0 109.758 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 m -93.26 97.86 10.89 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.5 mt -86.68 120.51 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -172.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.6 p -125.9 123.63 39.04 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -145.47 84.25 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.278 0.561 . . . . 0.0 109.665 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.85 69.63 1.33 Allowed Glycine 0 N--CA 1.485 1.918 0 N-CA-C 116.155 1.222 . . . . 0.0 116.155 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.1 m 56.12 60.54 3.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -156.81 89.03 1.07 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -97.73 104.49 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -174.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.6 mm -122.18 97.7 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -102.16 116.27 32.31 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.665 0.745 . . . . 0.0 110.27 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -103.97 100.46 10.24 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -166.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -102.32 118.0 35.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -137.86 170.63 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.974 0.893 . . . . 0.0 112.972 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.5 m -134.48 135.92 42.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.99 129.05 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 123.145 0.578 . . . . 0.0 110.646 -169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.31 23.48 77.36 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -143.73 140.01 29.76 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.29 116.13 10.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.328 0.585 . . . . 0.0 111.062 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.9 m -150.12 147.92 28.35 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 122.243 1.021 . . . . 0.0 111.032 -169.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.74 111.76 19.46 Favored 'General case' 0 CA--C 1.558 1.287 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -163.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.69 119.92 32.58 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.56 115.8 6.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.243 -0.91 . . . . 0.0 110.863 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.5 p -81.77 149.43 28.41 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.498 0.666 . . . . 0.0 111.086 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -32.75 72.76 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.6 p -64.35 -61.03 2.48 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.294 0.952 . . . . 0.0 112.913 163.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.24 97.65 0.34 Allowed Glycine 0 N--CA 1.479 1.552 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -150.14 -63.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.818 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.3 95.5 mttt 79.3 93.14 0.06 Allowed 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 124.679 1.191 . . . . 0.0 108.683 -165.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -113.6 116.5 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.775 0.83 . . . . 0.0 110.363 -159.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 111.46 6.34 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.466 0.706 . . . . 0.0 111.877 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.5 p -148.16 140.05 23.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.649 0.78 . . . . 0.0 109.134 -174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.38 118.83 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.6 t -97.99 104.6 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -93.72 120.49 34.05 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -79.48 122.31 26.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 171.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -119.31 129.37 54.84 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.417 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.18 -100.4 2.65 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.395 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.92 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.72 0.808 . . . . 0.0 111.697 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -132.37 51.88 2.12 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.329 1.052 . . . . 0.0 112.073 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.53 97.65 2.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.8 mt -81.36 147.73 29.69 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.891 0.877 . . . . 0.0 111.05 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.69 118.65 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.5 t -154.26 130.61 10.49 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.332 0.653 . . . . 0.0 109.651 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.2 t -116.8 126.04 52.49 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.646 0.778 . . . . 0.0 109.858 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -154.35 140.49 18.45 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.915 0.886 . . . . 0.0 110.294 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt 60.13 31.33 20.51 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.1 t30 51.96 51.62 16.1 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -161.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.1 mt -143.96 109.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -78.31 119.95 22.39 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 168.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 68.6 m -118.32 101.71 8.4 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -108.36 106.85 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -172.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -92.86 90.91 7.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.59 120.29 39.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.27 127.09 31.95 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.276 172.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -123.26 71.79 1.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.13 -92.3 1.15 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 123.104 0.383 . . . . 0.0 113.252 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -97.67 -36.64 10.19 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 164.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.73 104.3 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.889 1.222 . . . . 0.0 108.916 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.29 122.23 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.0 m -117.66 105.57 12.17 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -172.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -96.52 100.62 12.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.0 m -93.11 104.15 16.37 Favored 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.9 mtp -109.83 97.18 6.76 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 84.9 m -101.07 110.08 22.06 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.35 -58.09 4.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.826 0.851 . . . . 0.0 112.284 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.19 -81.81 0.04 OUTLIER Glycine 0 CA--C 1.536 1.389 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.58 -36.03 38.77 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 166.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.8 mt -85.11 123.35 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 119.538 1.063 . . . . 0.0 108.321 -170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.28 101.81 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -84.69 96.18 9.15 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.296 0.638 . . . . 0.0 109.598 172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -107.23 103.76 13.21 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -95.18 108.48 20.61 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.788 0.804 . . . . 0.0 109.606 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.64 111.34 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -129.52 100.68 5.63 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.133 0.573 . . . . 0.0 110.254 -166.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -82.05 137.35 35.08 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.79 -0.569 . . . . 0.0 111.489 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -73.56 106.16 5.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.534 0.734 . . . . 0.0 110.837 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 -172.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -73.03 -9.64 58.95 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 118.111 2.634 . . . . 0.0 118.111 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 89.1 p -67.78 115.42 7.31 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 121.058 1.754 . . . . 0.0 112.291 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.14 147.93 5.61 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.685 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.57 106.72 18.73 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -106.4 120.83 42.93 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.191 0.596 . . . . 0.0 109.479 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -82.66 129.03 34.88 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.427 0.691 . . . . 0.0 109.876 173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -70.63 132.29 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.763 0.792 . . . . 0.0 111.634 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -111.19 -63.15 1.44 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.464 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.9 t -126.9 101.26 6.5 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 119.249 0.931 . . . . 0.0 109.054 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -91.72 96.99 10.74 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.525 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -87.81 116.31 25.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 66.86 60.59 0.54 Allowed 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.165 0.986 . . . . 0.0 113.574 -172.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -78.43 -60.65 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.072 167.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.33 -37.15 80.26 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -173.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.77 94.29 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 168.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -66.44 -52.61 44.66 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 23.8 mmt -61.3 -43.74 98.38 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.28 -38.52 90.53 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 170.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.05 78.77 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -64.87 -40.5 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.16 65.0 0.07 OUTLIER Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.837 174.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.5 mt -127.9 146.95 61.0 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-N 117.784 0.792 . . . . 0.0 111.442 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.11 172.73 13.36 Favored 'Trans proline' 0 C--N 1.372 1.806 0 C-N-CA 123.164 2.576 . . . . 0.0 114.255 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -87.34 49.65 1.85 Allowed 'General case' 0 CA--C 1.574 1.871 0 CA-C-O 121.897 0.856 . . . . 0.0 112.827 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -125.64 -63.85 1.1 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 125.48 1.512 . . . . 0.0 107.972 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.55 -31.43 72.6 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -58.95 -49.98 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 C-N-CA 124.007 0.923 . . . . 0.0 111.831 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -62.31 -30.3 71.05 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.747 2.129 . . . . 0.0 116.747 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -67.0 -47.95 69.94 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 171.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.82 19.51 54.03 Favored Glycine 0 CA--C 1.548 2.103 0 N-CA-C 118.939 2.336 . . . . 0.0 118.939 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -78.88 -56.41 4.42 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 120.445 2.123 . . . . 0.0 112.51 174.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.94 -41.69 25.53 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 124.053 0.941 . . . . 0.0 113.403 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.4 mt -83.73 110.3 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -78.1 123.08 26.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.851 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.51 149.71 30.67 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 116.027 1.171 . . . . 0.0 116.027 -172.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.4 t -104.57 115.41 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.6 m -88.71 106.89 18.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.307 0.643 . . . . 0.0 109.543 175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.82 87.39 5.82 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.2 mt -91.88 131.0 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -171.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.7 t -124.44 98.6 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -84.26 117.01 23.27 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -117.04 77.14 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.49 -114.25 6.12 Favored Glycine 0 CA--C 1.546 1.99 0 C-N-CA 123.222 0.439 . . . . 0.0 113.128 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -78.0 -34.38 50.8 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -84.47 109.31 17.8 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 120.102 1.319 . . . . 0.0 110.402 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -96.48 148.39 22.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.969 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -146.02 127.94 15.46 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 161.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -120.55 159.23 25.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 m -138.69 101.45 4.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.71 125.83 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.2 m -132.4 99.68 4.75 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.52 89.49 4.7 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.182 0.593 . . . . 0.0 109.583 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.57 -107.38 2.48 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.044 -172.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 31' ' ' LYS . 41.6 t -121.79 80.76 1.73 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 160.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -149.93 89.27 1.59 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -97.71 110.54 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -164.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.59 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.5 102.47 9.53 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -120.36 128.02 52.85 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.344 -164.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -110.55 116.13 30.83 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -128.68 162.53 27.13 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.69 0.757 . . . . 0.0 111.392 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.2 m -131.55 132.13 43.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 m -70.51 133.94 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.553 0.741 . . . . 0.0 112.841 -171.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.72 -26.45 4.15 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -96.54 149.98 21.14 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.426 1.113 . . . . 0.0 109.515 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.56 106.31 9.26 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.575 0.702 . . . . 0.0 110.451 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 89.6 m -109.83 156.89 19.78 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.22 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -108.87 111.45 23.17 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.47 131.12 47.77 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.625 -166.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.92 87.3 3.47 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 111.792 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.8 p -101.49 165.85 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.017 1.389 . . . . 0.0 111.79 -164.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.411 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 13.2 ptp -65.4 -55.78 16.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 -171.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -98.91 -44.7 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.858 0.863 . . . . 0.0 113.136 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.58 -56.11 23.38 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.258 30.1 tt0 74.51 98.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.95 1.3 . . . . 0.0 111.477 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.283 2.2 ttmp? 65.73 74.3 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.822 1.249 . . . . 0.0 112.299 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.6 p -117.67 121.5 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.723 -162.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 119.73 15.46 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 123.063 0.545 . . . . 0.0 111.309 -177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -159.53 139.31 11.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.2 t -77.36 123.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.0 87.23 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -87.17 118.51 26.62 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.907 0.483 . . . . 0.0 109.853 -169.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.21 118.83 20.11 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.819 0.819 . . . . 0.0 110.305 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.47 133.6 47.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.233 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.86 -102.63 1.24 Allowed Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.02 -1.445 . . . . 0.0 113.269 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -137.23 -37.76 0.63 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.84 53.85 1.67 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.148 0.979 . . . . 0.0 112.683 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -148.01 100.11 3.15 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.2 mt -83.68 134.62 34.76 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.192 0.597 . . . . 0.0 110.005 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.24 114.04 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -172.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -142.78 164.82 29.07 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.946 0.879 . . . . 0.0 111.058 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.7 t -149.26 128.03 12.51 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.379 176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.72 126.51 11.84 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.725 0.81 . . . . 0.0 109.367 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? 57.92 49.66 11.54 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.263 3.5 t30 48.93 50.85 17.1 Favored 'General case' 0 CA--C 1.572 1.812 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 -169.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mt -144.24 110.78 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 103.32 -2.844 . . . . 0.0 103.32 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -83.01 113.73 20.78 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 168.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.2 m -109.58 109.07 19.73 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -114.47 107.01 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -173.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -99.08 89.2 4.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.51 127.04 46.98 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tt -83.35 115.01 21.82 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.28 76.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.95 -89.71 1.52 Allowed Glycine 0 N--CA 1.483 1.793 0 C-N-CA 122.965 0.317 . . . . 0.0 113.193 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -109.93 -30.89 7.6 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 166.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.34 114.75 26.83 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.3 tt -87.53 118.42 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 123.764 0.826 . . . . 0.0 108.875 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.9 m -111.62 107.85 17.13 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -100.02 100.23 11.08 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.3 m -96.3 100.01 11.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.8 mtp -105.65 108.46 19.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.4 t -114.1 112.13 22.72 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.933 0.493 . . . . 0.0 109.704 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.85 -23.2 61.49 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 168.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 155.81 -86.67 0.13 Allowed Glycine 0 CA--C 1.537 1.409 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.32 -37.98 22.7 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 64.9 mt -91.17 125.52 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.87 106.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -86.25 99.5 11.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.532 0.733 . . . . 0.0 109.803 173.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -97.76 106.59 18.92 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -101.07 102.25 13.18 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.94 106.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -163.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.9 m -124.41 108.43 12.16 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.18 0.592 . . . . 0.0 110.701 -167.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -85.58 145.13 27.5 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.209 0.604 . . . . 0.0 111.29 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.79 153.18 25.08 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 175.778 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.104 0.478 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -69.94 -10.42 58.51 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 118.209 2.67 . . . . 0.0 118.209 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -75.1 116.85 16.29 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 121.801 2.091 . . . . 0.0 111.662 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.33 159.09 15.4 Favored Glycine 0 CA--C 1.546 1.973 0 CA-C-O 121.975 0.764 . . . . 0.0 113.33 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -94.91 112.79 24.48 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -112.58 110.19 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -77.47 122.1 24.75 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.3 tp -75.8 135.19 40.26 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.048 0.451 . . . . 0.0 111.46 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -110.71 -68.51 0.92 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 117.864 -1.065 . . . . 0.0 108.41 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.2 m -90.3 151.92 21.27 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 120.137 1.335 . . . . 0.0 112.039 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.85 85.17 1.48 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 168.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -81.38 124.51 29.46 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.839 -171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 84.4 m-20 67.92 42.5 1.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -170.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -70.6 -43.23 69.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.623 -1.298 . . . . 0.0 113.819 174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.08 -55.05 28.73 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 120.188 1.358 . . . . 0.0 113.783 172.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.96 99.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -69.45 -52.06 30.3 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 118.185 -0.912 . . . . 0.0 113.231 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -38.92 92.64 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -62.15 -40.0 94.51 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.45 -38.11 71.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 47.7 pt -65.73 -42.1 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 135.16 49.24 0.08 OUTLIER Glycine 0 N--CA 1.484 1.889 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -102.71 150.18 37.46 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-N 118.607 1.204 . . . . 0.0 110.842 171.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.35 171.07 15.81 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 123.143 2.562 . . . . 0.0 114.246 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -83.02 41.9 0.77 Allowed 'General case' 0 CA--C 1.578 2.041 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -133.33 -57.47 0.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.643 1.577 . . . . 0.0 108.958 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -71.44 -27.71 63.46 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.89 -50.47 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.319 1.048 . . . . 0.0 111.821 165.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.53 -24.34 64.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -67.99 -51.29 48.94 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 119.423 1.011 . . . . 0.0 113.222 161.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.71 -18.82 76.14 Favored Glycine 0 CA--C 1.55 2.227 0 N-CA-C 120.092 2.797 . . . . 0.0 120.092 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 14.3 ptmm? -65.48 -50.98 63.32 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.25 2.025 . . . . 0.0 114.459 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.92 -43.21 55.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 171.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -80.04 105.55 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -86.88 105.25 16.93 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.13 133.19 11.76 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 116.07 1.188 . . . . 0.0 116.07 -161.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.27 114.52 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 123.604 0.762 . . . . 0.0 109.556 -174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -91.66 101.54 14.16 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -105.14 98.93 8.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -172.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.2 mt -94.85 129.02 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.21 105.66 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -89.79 144.14 26.21 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.65 0.738 . . . . 0.0 111.059 171.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -128.9 76.48 1.72 Allowed 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.4 -112.11 3.99 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 116.372 -0.376 . . . . 0.0 112.66 -171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -80.7 -23.38 39.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 168.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -89.28 101.49 14.16 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 120.228 1.376 . . . . 0.0 110.268 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -95.29 149.23 21.57 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.032 0.933 . . . . 0.0 112.201 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -142.47 138.97 31.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.39 127.05 20.33 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.352 0.661 . . . . 0.0 110.847 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 47.6 m -119.8 111.78 18.41 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.1 mt -112.09 116.59 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -114.28 86.86 2.51 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.08 110.29 22.17 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.288 0.635 . . . . 0.0 109.928 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.2 -112.19 4.38 Favored Glycine 0 N--CA 1.481 1.639 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -142.17 75.41 1.49 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 159.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.88 112.11 2.85 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 175.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -86.44 109.75 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.58 91.37 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.333 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -106.15 115.32 30.03 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.742 0.782 . . . . 0.0 109.489 -166.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.19 139.39 53.97 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.734 -163.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -141.71 125.11 16.59 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -136.78 168.28 19.83 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.022 0.915 . . . . 0.0 111.697 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.6 m -130.18 132.01 45.86 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 168.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 m -67.65 132.64 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 C-N-CA 123.348 0.659 . . . . 0.0 112.459 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.53 -30.69 4.8 Favored Glycine 0 CA--C 1.554 2.511 0 N-CA-C 117.728 1.851 . . . . 0.0 117.728 -167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -99.59 141.51 32.29 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.612 1.165 . . . . 0.0 109.488 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -78.06 119.55 21.65 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.566 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.5 m -135.01 143.95 47.07 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.363 0.665 . . . . 0.0 110.313 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.05 121.93 20.05 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.848 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.8 mt -108.54 121.27 44.63 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.63 101.51 6.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . 0.267 2.2 t -78.51 -179.82 6.61 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.48 0.657 . . . . 0.0 112.769 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.1 mmm -59.58 -51.58 69.22 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.2 t -73.88 167.13 22.07 Favored 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 118.966 0.803 . . . . 0.0 111.534 160.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.99 89.28 0.97 Allowed Glycine 0 N--CA 1.485 1.906 0 O-C-N 121.779 -0.576 . . . . 0.0 114.105 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -159.2 116.66 2.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -98.11 93.74 6.44 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 p -105.89 118.37 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.87 -156.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 109.56 16.15 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.625 0.77 . . . . 0.0 109.795 -176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -144.45 140.43 28.95 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.86 0.838 . . . . 0.0 109.953 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.75 133.05 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.858 0.863 . . . . 0.0 108.723 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.06 118.97 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -96.69 123.75 40.47 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 46.3 tp -85.55 123.58 31.14 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -100.01 114.43 27.72 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.18 -119.36 11.55 Favored Glycine 0 CA--C 1.546 2.016 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.763 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -130.66 7.72 4.86 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -139.32 24.61 2.49 Favored 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -170.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.8 120.8 5.68 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.231 1.378 . . . . 0.0 108.727 173.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.9 mt -109.25 121.56 45.44 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 m -111.98 120.59 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 123.999 0.92 . . . . 0.0 108.91 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.6 t -156.28 136.03 12.55 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.347 0.659 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -116.26 119.52 36.01 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -80.93 -89.34 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 118.831 -0.604 . . . . 0.0 110.785 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -97.48 -83.39 0.4 Allowed 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -125.11 69.96 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 152.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.3 102.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -85.59 99.13 11.06 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -97.8 125.01 42.42 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.668 0.787 . . . . 0.0 110.582 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.93 98.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -95.34 86.51 4.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -106.38 124.89 50.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.941 0.876 . . . . 0.0 109.176 -167.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.59 112.93 22.06 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -115.59 72.21 0.8 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.477 0.711 . . . . 0.0 109.702 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.87 76.54 0.26 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.772 -0.58 . . . . 0.0 114.496 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 61.4 9.42 2.61 Favored 'General case' 0 CA--C 1.575 1.911 0 N-CA-C 118.322 2.712 . . . . 0.0 118.322 -170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.6 mt -120.11 106.36 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 -168.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.8 mm -80.58 104.32 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -103.48 100.0 9.85 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -95.39 110.79 22.78 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.4 m -110.0 96.45 6.24 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -173.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.2 mtt -103.03 119.4 38.79 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 109.91 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 57.4 m -111.77 112.99 25.07 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -74.26 -83.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.7 0.8 . . . . 0.0 110.168 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -103.64 -73.16 0.93 Allowed Glycine 0 N--CA 1.48 1.578 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 166.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -138.82 63.0 1.53 Allowed 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.86 105.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 169.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.8 t -87.48 94.49 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -82.81 101.84 11.21 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.475 0.71 . . . . 0.0 109.198 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -114.32 105.99 13.79 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.36 0.6 . . . . 0.0 110.029 -174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -76.22 155.36 34.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.326 0.65 . . . . 0.0 111.878 168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.0 mm -133.8 105.54 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 168.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.4 t -96.52 179.15 5.11 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.599 0.714 . . . . 0.0 112.575 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.13 131.33 7.51 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -74.74 117.63 16.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.954 -0.466 . . . . 0.0 111.006 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 -178.084 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -75.62 -12.33 60.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.8 t -73.15 115.11 12.08 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 121.602 2.001 . . . . 0.0 112.06 -173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.61 166.61 28.89 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 122.207 0.893 . . . . 0.0 113.815 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -88.55 119.58 29.14 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -124.27 104.58 8.89 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -83.6 134.64 34.79 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.972 0.891 . . . . 0.0 110.414 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -60.73 133.02 55.68 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 113.893 -1.503 . . . . 0.0 112.141 172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -113.14 -64.26 1.33 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.592 0.757 . . . . 0.0 109.827 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 t -123.52 130.05 52.11 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.675 0.79 . . . . 0.0 109.875 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -99.44 120.12 39.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 33.2 tt0 -70.45 -53.56 15.86 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -139.5 81.25 1.82 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.89 -60.24 2.45 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.743 165.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -64.92 -39.47 93.56 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -173.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.35 -44.01 89.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 169.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -66.76 -50.61 62.15 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.4 mmt -61.36 -39.68 91.53 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -67.19 -37.74 84.2 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.77 -41.94 78.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.9 pt -63.33 -39.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.59 62.92 0.05 OUTLIER Glycine 0 CA--C 1.542 1.728 0 CA-C-O 119.141 -0.811 . . . . 0.0 113.335 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -140.9 144.02 33.93 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-N 117.761 0.781 . . . . 0.0 110.698 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.1 168.62 24.28 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.078 2.519 . . . . 0.0 113.659 173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.68 29.31 0.45 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.1 -59.89 1.67 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 125.061 1.344 . . . . 0.0 110.101 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.4 -30.82 70.79 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.2 mt -66.65 -51.66 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 124.318 1.047 . . . . 0.0 111.166 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -58.0 -34.28 69.82 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -66.25 -46.3 77.59 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.42 21.01 44.51 Favored Glycine 0 CA--C 1.549 2.21 0 N-CA-C 118.744 2.258 . . . . 0.0 118.744 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -78.12 -42.81 30.75 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.045 1.922 . . . . 0.0 114.624 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.32 -38.05 22.6 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.61 113.86 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -100.4 114.86 28.73 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.181 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.24 169.31 21.59 Favored Glycine 0 N--CA 1.481 1.652 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 -169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.1 t -95.14 117.67 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t -87.77 102.12 14.35 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 168.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -92.54 101.29 13.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.3 mt -92.47 126.78 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.8 93.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 173.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -97.98 123.56 42.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -125.13 75.32 1.44 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 172.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.24 -109.81 3.07 Favored Glycine 0 CA--C 1.545 1.912 0 C-N-CA 123.094 0.378 . . . . 0.0 113.147 -174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -20.93 50.13 Favored 'General case' 0 CA--C 1.567 1.611 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 170.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -93.43 104.3 16.45 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.307 1.412 . . . . 0.0 109.874 -172.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -105.86 151.82 24.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.181 0.991 . . . . 0.0 112.469 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -154.57 159.1 40.69 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.256 154.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.87 127.87 19.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.729 -0.607 . . . . 0.0 110.344 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.7 m -114.08 100.71 8.59 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.02 135.57 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -133.41 91.46 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.94 -137.64 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.529 0.731 . . . . 0.0 110.436 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.55 -92.22 0.32 Allowed Glycine 0 N--CA 1.485 1.903 0 O-C-N 121.45 -0.781 . . . . 0.0 112.234 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.9 m -104.64 41.18 1.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 166.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -142.78 85.89 1.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.46 90.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.9 mt -122.5 112.38 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -162.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.38 126.47 53.46 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.409 0.684 . . . . 0.0 109.74 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -122.72 117.93 26.89 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.6 133.45 54.54 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.68 0.792 . . . . 0.0 109.78 -175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -158.52 155.57 28.65 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.331 -166.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 m -117.56 131.04 56.76 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 167.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 m -70.58 129.58 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.32 0.648 . . . . 0.0 111.421 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.11 27.7 61.68 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -162.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.41 137.55 21.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -77.2 103.58 7.22 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.967 0.507 . . . . 0.0 110.261 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.9 m -130.4 141.26 50.55 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.545 0.738 . . . . 0.0 111.04 -167.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.96 123.52 24.45 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.28 120.92 43.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.05 111.65 5.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 0.0 110.968 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.7 p -77.92 161.42 27.57 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.231 1.015 . . . . 0.0 112.372 -173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.0 mtm -60.97 -40.92 95.23 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.2 p -62.16 -57.09 12.8 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 164.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.59 88.24 0.47 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -140.52 -51.06 0.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -169.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.277 20.0 mtpp 70.1 86.51 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.825 1.25 . . . . 0.0 110.672 -170.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.11 116.99 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.614 0.766 . . . . 0.0 110.412 -159.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.3 109.71 9.05 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.318 0.647 . . . . 0.0 111.639 -176.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -144.21 140.31 29.22 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.681 0.792 . . . . 0.0 109.817 -173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.9 t -82.79 119.2 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -95.04 119.48 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -97.43 122.95 41.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -85.43 119.62 25.98 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -105.89 124.86 50.24 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.404 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.62 -103.61 1.98 Allowed Glycine 0 CA--C 1.541 1.693 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.875 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -137.76 -38.19 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -140.92 53.65 1.58 Allowed 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.023 0.929 . . . . 0.0 112.7 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -150.87 101.15 2.88 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.5 mt -97.02 128.14 43.69 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.617 0.767 . . . . 0.0 110.148 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.6 m -106.68 128.33 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 0.0 109.338 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -145.03 111.86 5.87 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.641 0.734 . . . . 0.0 109.991 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -109.77 127.8 54.88 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.359 1.064 . . . . 0.0 109.652 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.294 13.3 p90 -126.48 -98.15 0.4 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.382 -168.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.71 77.32 1.72 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.011 1.278 . . . . 0.0 109.235 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.1 m120 55.63 29.05 12.9 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -170.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.4 mt -137.22 102.0 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 -171.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.41 118.83 25.19 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 169.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 t -101.34 104.79 15.79 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.216 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.66 98.21 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 m -96.34 86.84 4.3 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.39 124.33 49.43 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -84.52 120.59 26.5 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.265 0.626 . . . . 0.0 109.529 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.85 77.13 1.34 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.0 -102.63 1.81 Allowed Glycine 0 N--CA 1.484 1.887 0 C-N-CA 123.122 0.392 . . . . 0.0 113.358 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.71 -44.44 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.894 -0.574 . . . . 0.0 112.461 163.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -79.37 110.63 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 119.491 1.042 . . . . 0.0 108.841 -170.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 tt -85.67 115.6 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 168.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.5 m -101.63 101.35 11.87 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.06 102.67 13.19 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.6 m -105.05 95.26 5.72 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -167.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.7 mtm -91.28 111.99 23.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.759 0.824 . . . . 0.0 109.286 173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.5 m -114.05 115.9 28.31 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.44 -60.96 1.97 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.767 0.827 . . . . 0.0 111.809 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.39 -82.06 0.03 OUTLIER Glycine 0 N--CA 1.477 1.37 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.6 -30.97 41.65 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 166.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 120.35 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.84 100.19 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -85.73 99.92 11.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.704 0.801 . . . . 0.0 108.99 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 40.5 ttmt -108.61 111.83 23.85 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -88.06 112.8 23.05 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.4 mt -101.02 95.2 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.6 m -117.3 99.86 7.3 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.165 0.507 . . . . 0.0 110.509 -162.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -74.11 139.15 44.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.399 0.68 . . . . 0.0 111.843 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.02 115.89 12.88 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.511 0.725 . . . . 0.0 109.947 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.548 0.886 0 CA-C-O 121.748 0.785 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -66.66 -10.83 50.27 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.5 p -65.08 112.69 3.48 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 120.563 1.528 . . . . 0.0 113.038 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.31 163.86 18.26 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.355 0.975 . . . . 0.0 112.722 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -107.77 106.69 17.12 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -113.48 105.93 13.95 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -168.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -81.06 137.38 36.02 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.9 0.857 . . . . 0.0 110.477 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.2 tp -67.23 134.86 52.47 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.581 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -115.11 -45.96 2.93 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.427 1.091 . . . . 0.0 111.652 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 p -148.89 114.01 5.49 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.387 0.675 . . . . 0.0 109.186 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -107.32 111.37 23.69 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.635 0.774 . . . . 0.0 109.239 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -90.07 116.54 28.17 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 75.06 61.75 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.615 1.166 . . . . 0.0 114.097 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -72.22 -63.62 1.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.988 -1.07 . . . . 0.0 110.986 160.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.89 -35.72 77.21 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.42 -46.34 89.02 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 167.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -65.77 -49.52 68.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 25.6 mmt -61.8 -37.19 83.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -69.7 -41.99 74.66 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -29.88 64.98 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 pt -65.19 -45.66 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 129.35 73.9 0.15 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 123.85 0.738 . . . . 0.0 111.43 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.0 mt -136.98 146.62 55.59 Favored Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 123.476 0.71 . . . . 0.0 110.592 173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.7 170.84 14.37 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.358 2.705 . . . . 0.0 114.68 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.45 -38.92 69.66 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.6 -49.11 76.54 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.48 -27.34 64.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.5 mt -65.55 -57.5 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 119.723 1.147 . . . . 0.0 110.162 165.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -54.73 -18.86 5.18 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 118.642 2.83 . . . . 0.0 118.642 172.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -65.85 -46.61 77.85 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.09 46.34 1.12 Allowed Glycine 0 CA--C 1.543 1.816 0 CA-C-O 117.447 -1.751 . . . . 0.0 115.588 167.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -66.31 92.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 119.572 1.686 . . . . 0.0 113.851 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 47.9 55.37 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -163.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.54 115.96 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -86.96 133.51 33.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.35 0.66 . . . . 0.0 111.534 -169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.86 -165.16 13.69 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-O 122.368 0.982 . . . . 0.0 114.259 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.5 t -93.54 123.87 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.318 0.58 . . . . 0.0 110.842 -155.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.0 t -100.49 102.51 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -102.99 92.72 4.67 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.29 132.78 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -121.52 102.95 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -82.27 123.14 28.78 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -122.37 75.19 1.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.46 -112.66 4.63 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.041 0.353 . . . . 0.0 113.136 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.71 -31.47 32.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -86.7 114.83 23.72 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 120.396 1.453 . . . . 0.0 110.049 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -101.27 149.69 23.75 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.868 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -145.43 129.79 17.76 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 168.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -138.36 141.15 39.68 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.263 0.625 . . . . 0.0 111.801 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 m -119.86 112.49 19.28 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.4 125.0 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 m -136.79 117.95 14.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.2 108.53 6.86 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.63 -111.15 3.39 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.3 m -135.83 69.45 1.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.51 104.46 3.07 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.35 106.21 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.81 93.78 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -93.96 119.87 33.45 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.628 0.728 . . . . 0.0 109.294 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -125.48 149.83 47.91 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.945 -171.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -147.64 136.12 21.69 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.381 0.61 . . . . 0.0 109.521 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -140.29 170.3 16.08 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.284 1.04 . . . . 0.0 112.044 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.4 m -138.98 122.22 17.0 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.2 m -70.56 132.4 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 122.997 0.519 . . . . 0.0 112.031 -173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.87 -43.46 2.04 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 116.689 1.436 . . . . 0.0 116.689 -167.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -88.41 152.62 21.78 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.337 1.055 . . . . 0.0 110.942 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.81 116.72 15.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 166.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.1 m -134.54 142.66 47.06 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.991 0.9 . . . . 0.0 110.172 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 130.74 42.29 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -170.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -127.98 114.58 17.31 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.75 108.57 8.69 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.1 p -70.79 158.22 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.308 1.052 . . . . 0.0 113.345 -174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 49.7 mtt -57.76 -25.01 59.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 164.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 m -73.1 -72.91 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.679 1.127 . . . . 0.0 110.137 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.73 73.69 0.02 OUTLIER Glycine 0 CA--C 1.54 1.629 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -161.37 124.06 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -90.95 96.68 10.75 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.75 120.95 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.165 -155.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.66 117.19 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.43 0.692 . . . . 0.0 111.513 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -152.36 141.57 21.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.126 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.4 t -78.91 135.7 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.52 119.66 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 173.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -98.78 128.03 44.89 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.693 0.759 . . . . 0.0 109.567 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -92.25 126.56 37.39 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.628 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.63 118.99 35.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.724 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.68 17.95 60.96 Favored Glycine 0 CA--C 1.555 2.552 0 N-CA-C 120.317 2.887 . . . . 0.0 120.317 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 2.3 t70 66.12 11.41 7.8 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -169.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -153.74 22.07 0.52 Allowed 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -173.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -158.15 95.08 1.35 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 121.159 1.8 . . . . 0.0 108.786 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 25.3 mt -88.09 138.0 31.83 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.68 0.792 . . . . 0.0 110.104 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.75 119.11 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.04 113.27 3.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.11 0.957 . . . . 0.0 109.417 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -92.95 130.85 38.39 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 160.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -83.68 -75.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.328 -169.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.24 -71.82 0.72 Allowed 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -105.75 -36.7 6.96 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 172.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.9 mt -80.86 130.61 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.465 1.03 . . . . 0.0 109.68 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -68.48 155.02 40.71 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.027 0.931 . . . . 0.0 112.466 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -153.14 102.35 2.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.4 t -116.45 105.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.3 m -104.15 92.06 4.2 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -170.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.87 116.03 31.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.393 0.616 . . . . 0.0 110.187 -167.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.89 119.69 26.48 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.223 1.009 . . . . 0.0 109.158 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -117.22 80.04 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.685 0.794 . . . . 0.0 109.139 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.07 -87.58 1.52 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -177.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -138.77 59.95 1.61 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 153.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.4 mm -139.69 91.93 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 -173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.4 mt -85.61 115.03 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.8 m -105.23 100.13 9.72 Favored 'General case' 0 CA--C 1.557 1.246 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.01 105.83 17.78 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.073 0.949 . . . . 0.0 108.562 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 45.4 m -104.86 99.08 8.73 Favored 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.0 mtt -101.64 108.54 20.12 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.6 m -113.39 117.31 31.41 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.75 -27.62 55.44 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.69 -84.41 0.12 Allowed Glycine 0 CA--C 1.536 1.357 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -79.57 -45.1 19.84 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 170.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.83 125.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 67.5 t -108.17 101.65 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -86.59 99.29 11.61 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.505 0.722 . . . . 0.0 110.205 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -108.28 107.37 17.94 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -97.93 113.97 25.94 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.926 0.89 . . . . 0.0 108.961 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.01 102.76 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 89.2 p -100.67 108.04 19.81 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.392 0.615 . . . . 0.0 110.27 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -89.53 148.3 23.47 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.802 0.841 . . . . 0.0 109.81 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -57.13 138.08 55.01 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 113.863 1.061 . . . . 0.0 113.863 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.487 1.407 0 C-N-CA 123.524 0.73 . . . . 0.0 110.73 -167.42 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.549 0.921 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -82.42 1.04 39.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 t -78.51 114.32 17.32 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 121.92 2.145 . . . . 0.0 110.994 -176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.56 160.2 12.61 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 121.919 0.733 . . . . 0.0 113.179 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -84.46 127.15 33.86 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.39 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -122.32 96.23 4.96 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -83.55 136.67 34.17 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.588 0.709 . . . . 0.0 109.935 177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.413 HD21 HE21 ' A' ' 12' ' ' GLN . 30.8 tp -61.99 151.95 33.68 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.513 -178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -131.87 -52.32 0.98 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.831 0.852 . . . . 0.0 110.495 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 p -141.98 108.56 5.34 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 119.266 0.939 . . . . 0.0 110.465 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.413 HE21 HD21 ' A' ' 9' ' ' LEU . 3.2 pt20 -86.43 103.43 14.97 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.924 0.89 . . . . 0.0 109.336 169.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -90.21 118.46 29.75 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 49.6 m-20 65.64 62.36 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -173.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -82.64 -55.41 4.47 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.26 164.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.36 -46.3 80.7 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.74 79.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 167.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -67.86 -51.63 46.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.7 mmt -64.81 -40.19 94.81 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -59.15 -46.3 88.72 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 165.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.07 85.55 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 116.855 2.169 . . . . 0.0 116.855 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 pt -65.66 -40.33 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 169.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.5 74.31 0.31 Allowed Glycine 0 N--CA 1.479 1.558 0 CA-C-N 118.837 0.744 . . . . 0.0 112.611 174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 mt -128.76 150.77 75.82 Favored Pre-proline 0 N--CA 1.493 1.693 0 C-N-CA 123.251 0.621 . . . . 0.0 112.121 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.45 170.6 19.63 Favored 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.223 2.615 . . . . 0.0 114.079 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -56.82 -32.72 66.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 172.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.46 -59.18 5.87 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.1 mt -68.69 -32.41 72.22 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.5 mt -68.28 -58.5 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.745 1.157 . . . . 0.0 111.077 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -71.97 -14.11 61.81 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 117.623 2.453 . . . . 0.0 117.623 -171.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -66.62 -59.78 3.3 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 120.302 1.41 . . . . 0.0 112.191 162.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 21.36 7.36 Favored Glycine 0 CA--C 1.551 2.31 0 N-CA-C 118.867 2.307 . . . . 0.0 118.867 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -62.58 -44.42 96.36 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 120.095 1.948 . . . . 0.0 115.597 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -150.6 75.39 1.22 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.985 0.811 . . . . 0.0 109.05 164.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.1 mt -129.04 113.22 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -82.49 122.52 28.15 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.59 176.85 22.11 Favored Glycine 0 CA--C 1.542 1.745 0 CA-C-O 122.685 1.158 . . . . 0.0 113.805 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -92.57 120.9 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.485 -0.858 . . . . 0.0 109.883 -160.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.0 m -104.83 99.95 9.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 165.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.83 108.18 19.3 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -171.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.9 mt -86.96 125.83 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.8 t -107.83 100.1 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.29 122.39 35.64 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.685 0.794 . . . . 0.0 108.931 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -135.96 85.18 2.14 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.829 0.851 . . . . 0.0 108.804 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.48 -125.36 14.02 Favored Glycine 0 CA--C 1.546 1.985 0 C-N-CA 123.28 0.466 . . . . 0.0 113.495 -174.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -75.1 -24.2 58.07 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 165.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -86.6 133.23 33.73 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 119.71 1.141 . . . . 0.0 110.755 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -129.24 151.33 50.02 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.3 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 147.78 30.57 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.941 164.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -145.29 126.82 15.07 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.958 0.503 . . . . 0.0 110.956 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.1 m -114.78 111.57 21.45 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -94.67 114.96 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -107.95 108.67 19.92 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 166.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -88.15 -96.81 0.09 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.365 0.666 . . . . 0.0 110.566 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.73 -90.88 0.65 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 168.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.0 t -125.5 77.01 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 160.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -152.09 96.47 2.2 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -174.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -95.53 117.81 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.4 mt -123.28 106.04 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -90.13 125.16 35.34 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.27 0.628 . . . . 0.0 109.857 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -125.12 149.77 47.53 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.872 0.869 . . . . 0.0 109.509 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.4 125.16 13.37 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -133.45 171.76 13.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.157 0.98 . . . . 0.0 112.097 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -135.44 136.3 41.23 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.35 129.4 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.2 25.69 75.24 Favored Glycine 0 CA--C 1.552 2.371 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -135.87 143.15 44.9 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.81 122.29 20.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.424 0.63 . . . . 0.0 110.435 171.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.1 m -139.09 133.8 32.05 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.131 -173.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -79.62 108.72 13.38 Favored 'General case' 0 CA--C 1.556 1.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.575 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.56 123.17 40.14 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.01 101.25 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.9 p -82.34 162.95 22.05 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 122.117 0.96 . . . . 0.0 112.877 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -47.31 -44.53 23.52 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.1 t -136.34 116.41 13.35 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 166.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.63 -134.67 3.53 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -133.89 -101.61 0.25 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.83 100.88 3.47 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.5 116.29 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.72 0.808 . . . . 0.0 111.001 -167.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -70.92 115.67 10.33 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.57 0.748 . . . . 0.0 111.705 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -149.35 134.52 18.19 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.612 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.07 120.87 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 175.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.2 t -99.65 88.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -93.63 121.66 35.28 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -168.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 tp -80.98 121.37 25.95 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.14 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.34 144.29 31.55 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.479 1.133 . . . . 0.0 110.89 172.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.1 -110.67 3.63 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.4 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -133.16 -22.42 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.93 53.06 1.15 Allowed 'General case' 0 CA--C 1.566 1.576 0 C-N-CA 124.597 1.159 . . . . 0.0 112.161 -172.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.15 99.18 2.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.06 123.03 33.58 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.273 0.629 . . . . 0.0 109.872 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.03 118.24 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -145.55 116.89 7.96 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.39 0.614 . . . . 0.0 110.761 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.3 t -105.66 124.14 49.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.054 0.942 . . . . 0.0 109.857 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.9 108.59 5.93 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 54.02 54.83 9.11 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.273 3.3 t30 47.8 49.8 16.23 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 -167.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -135.22 91.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -80.62 117.22 21.12 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -111.67 102.32 10.64 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.549 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.4 t -104.35 99.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 106.347 -1.724 . . . . 0.0 106.347 -173.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 m -94.87 86.32 4.65 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -101.44 122.14 43.22 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -173.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.24 110.65 18.71 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -107.56 76.09 1.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.49 -93.22 1.63 Allowed Glycine 0 N--CA 1.483 1.808 0 C-N-CA 123.017 0.341 . . . . 0.0 112.822 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -100.59 -41.27 7.02 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.47 0.708 . . . . 0.0 112.309 162.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.66 110.33 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 C-N-CA 124.101 0.96 . . . . 0.0 108.863 -167.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.46 120.71 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 123.91 0.884 . . . . 0.0 108.717 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.8 m -107.68 100.7 10.07 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -96.58 104.69 16.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.8 m -106.48 95.38 5.71 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -169.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.2 mtm -93.29 98.69 11.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.581 0.752 . . . . 0.0 109.399 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.6 m -94.13 107.31 19.25 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.9 tp -70.36 -56.64 6.19 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.252 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.79 -85.19 0.05 OUTLIER Glycine 0 CA--C 1.536 1.358 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.46 -32.78 60.75 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 163.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.8 mt -85.79 121.05 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -172.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -110.17 101.88 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -86.49 93.1 9.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.42 0.688 . . . . 0.0 110.282 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -101.81 104.58 15.35 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -93.76 105.91 17.91 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.1 mt -99.13 102.73 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 -170.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 25.3 m -123.57 108.93 13.16 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.24 0.616 . . . . 0.0 110.602 -162.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -76.85 137.42 39.17 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.236 0.614 . . . . 0.0 111.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.1 116.06 15.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.046 0.538 . . . . 0.0 109.935 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 30.0 mm . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -172.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.6 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.66 -3.05 49.14 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -73.39 110.28 7.56 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.771 2.078 . . . . 0.0 111.201 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.17 149.7 7.44 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-O 121.979 0.766 . . . . 0.0 112.506 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -92.43 105.94 18.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -109.25 108.73 19.45 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -87.85 135.52 33.36 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.123 0.964 . . . . 0.0 110.279 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.5 tp -74.69 118.11 17.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.718 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.99 -56.34 3.73 Favored 'General case' 0 CA--C 1.56 1.364 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.577 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.2 t -144.77 117.31 8.59 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 118.935 0.788 . . . . 0.0 108.943 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -99.32 104.21 16.1 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 170.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.03 127.63 34.29 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.546 0.738 . . . . 0.0 109.301 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 79.4 m-20 65.53 50.66 1.63 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -66.53 -60.66 2.53 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 118.403 -0.808 . . . . 0.0 112.102 166.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.42 -36.8 83.5 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.03 86.02 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 168.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.53 -47.43 19.54 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.738 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 74' ' ' MET . 9.9 mmt -62.22 -45.81 91.69 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -56.05 -43.6 78.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 167.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.33 -44.85 82.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.4 pt -66.72 -36.43 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 171.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 119.11 61.32 0.27 Allowed Glycine 0 N--CA 1.482 1.721 0 CA-C-N 118.872 0.76 . . . . 0.0 114.703 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -102.65 137.66 19.41 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.456 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.18 -179.46 3.57 Favored 'Trans proline' 0 CA--C 1.565 2.058 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -57.16 -28.82 63.1 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 169.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -56.76 -58.91 6.05 Favored 'General case' 0 CA--C 1.563 1.479 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 170.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.69 -32.05 46.87 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.59 -59.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 120.912 1.687 . . . . 0.0 110.919 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -61.91 -23.97 66.67 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -65.43 -50.33 65.81 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.96 28.56 9.22 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 117.698 1.839 . . . . 0.0 117.698 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -64.74 0.94 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 119.893 1.847 . . . . 0.0 112.705 170.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -73.98 -43.16 59.07 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 174.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.3 mt -86.13 111.32 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -87.59 -65.32 1.03 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.383 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.65 174.94 50.12 Favored Glycine 0 CA--C 1.545 1.958 0 N-CA-C 116.889 1.515 . . . . 0.0 116.889 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.15 114.77 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 114.971 -0.615 . . . . 0.0 109.686 -164.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.9 m -87.26 108.08 18.78 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 162.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -114.28 93.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 122.776 0.43 . . . . 0.0 109.947 -162.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -88.68 134.66 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.06 122.15 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.496 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -90.91 122.9 34.0 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -127.59 73.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.55 -115.78 6.93 Favored Glycine 0 CA--C 1.545 1.915 0 C-N-CA 123.215 0.436 . . . . 0.0 113.379 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -80.47 -24.64 39.36 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -90.98 122.16 33.41 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.055 1.298 . . . . 0.0 109.802 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -122.05 148.22 45.12 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.975 -175.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -143.28 135.48 27.03 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -135.39 122.46 21.42 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.129 0.572 . . . . 0.0 110.912 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 m -111.04 110.85 21.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 57.3 mt -99.69 124.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -123.75 99.52 6.32 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.75 84.93 2.23 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.482 0.658 . . . . 0.0 110.349 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.38 58.41 6.58 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 -174.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.2 m 54.35 49.68 17.93 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -125.48 79.23 1.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.01 109.95 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -164.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -125.2 101.53 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -98.54 119.19 36.83 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.872 0.844 . . . . 0.0 109.728 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -111.31 133.15 53.84 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.434 -1.257 . . . . 0.0 107.628 -175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -136.31 111.98 9.39 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -121.04 163.59 18.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.675 0.75 . . . . 0.0 111.985 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.7 m -134.48 131.26 37.85 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 m -71.26 136.0 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -170.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.19 -17.15 7.94 Favored Glycine 0 CA--C 1.556 2.617 0 N-CA-C 118.582 2.193 . . . . 0.0 118.582 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -108.1 145.85 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.759 1.224 . . . . 0.0 108.816 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.88 103.6 4.46 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.126 0.57 . . . . 0.0 111.236 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.9 m -134.44 146.35 49.72 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.743 0.817 . . . . 0.0 111.062 -167.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -66.03 137.76 57.32 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.44 108.48 13.71 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 165.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.79 108.76 5.93 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.91 0.484 . . . . 0.0 110.119 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.9 p -74.07 155.95 37.96 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' SD ' ' A' ' 19' ' ' MET . 15.0 ptp -60.57 -25.84 66.5 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 169.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.9 m -62.07 -66.66 0.5 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.976 0.807 . . . . 0.0 111.465 162.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.68 80.16 0.1 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -129.0 -56.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 123.07 0.548 . . . . 0.0 112.135 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.263 34.1 ttmt 65.86 74.01 0.37 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.507 1.123 . . . . 0.0 111.163 -169.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.66 113.91 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.714 -160.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.91 124.67 25.89 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.938 0.875 . . . . 0.0 111.334 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 139.28 18.84 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.539 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -76.45 116.12 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.0 t -102.1 92.44 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -91.96 113.3 25.53 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.28 0.562 . . . . 0.0 110.102 -167.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.31 127.08 34.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.028 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.82 122.57 43.74 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.0 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.17 5.49 71.49 Favored Glycine 0 CA--C 1.555 2.545 0 N-CA-C 120.364 2.906 . . . . 0.0 120.364 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.337 6.0 t70 70.66 -2.64 2.17 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -169.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -143.93 36.05 1.26 Allowed 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.3 tttp -156.85 106.96 2.29 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.49 121.28 35.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -120.78 106.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 -167.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.3 t -146.06 160.84 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.914 0.864 . . . . 0.0 111.101 -172.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -150.42 127.19 10.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.72 108.18 4.83 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? 57.05 61.87 2.43 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.265 19.6 m120 62.72 6.85 2.25 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 -172.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 50.5 mt -108.05 102.74 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 -175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.9 tmtm? -86.55 104.4 15.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.9 m -102.49 118.88 37.82 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.282 0.633 . . . . 0.0 109.679 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.42 101.78 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.7 m -96.87 88.24 4.51 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -99.83 122.78 43.31 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -80.37 111.31 16.64 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -105.3 75.07 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.76 -85.9 1.56 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 112.298 -0.321 . . . . 0.0 112.298 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -115.28 -37.86 3.96 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.759 0.824 . . . . 0.0 112.646 162.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.68 115.07 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.384 0 C-N-CA 124.295 1.038 . . . . 0.0 108.333 -170.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.2 tt -92.28 121.43 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.816 0.846 . . . . 0.0 109.214 -177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.6 m -112.0 107.94 17.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -172.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 50.8 m -98.76 109.16 21.96 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp -110.13 105.12 14.1 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.4 m -103.0 113.59 27.18 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -168.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 tp -115.9 98.39 6.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.03 -96.89 1.11 Allowed Glycine 0 N--CA 1.483 1.78 0 N-CA-C 112.261 -0.335 . . . . 0.0 112.261 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -137.21 62.57 1.59 Allowed 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 159.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.54 105.93 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 103.517 -2.772 . . . . 0.0 103.517 172.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -93.31 90.14 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -86.74 91.09 8.51 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -98.88 112.83 24.81 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.908 -173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -95.08 100.82 12.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.7 109.8 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.4 m -124.46 109.59 13.46 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -72.18 167.78 19.59 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 172.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -84.48 152.3 24.05 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.081 0.467 . . . . 0.0 111.575 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 174.277 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.3 p . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -70.47 -34.57 72.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.9 t -74.65 110.47 8.97 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 120.405 1.457 . . . . 0.0 111.161 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.52 -144.38 5.38 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-O 122.28 0.933 . . . . 0.0 114.357 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.35 121.03 6.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -131.79 93.89 3.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -165.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -83.95 139.26 32.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.731 -0.606 . . . . 0.0 111.621 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.13 118.72 7.17 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.083 0.944 . . . . 0.0 113.418 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -87.44 -56.77 3.21 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.878 173.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.0 t -147.25 145.62 29.5 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.541 0.736 . . . . 0.0 109.878 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -106.82 136.81 46.01 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.177 0.591 . . . . 0.0 109.515 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -79.04 -64.33 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.61 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -134.42 78.29 1.74 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -73.22 -58.24 3.45 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.443 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -69.14 -39.36 78.9 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -171.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.44 91.17 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -66.29 -50.93 62.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.3 mmt -63.6 -40.38 96.79 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -61.98 -43.75 98.18 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 166.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.25 -38.91 85.93 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.4 pt -62.98 -42.21 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 168.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.42 71.21 0.11 Allowed Glycine 0 CA--C 1.539 1.581 0 C-N-CA 123.76 0.695 . . . . 0.0 112.633 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -132.27 147.77 67.05 Favored Pre-proline 0 CA--C 1.569 1.681 0 C-N-CA 123.235 0.614 . . . . 0.0 111.083 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.35 176.14 9.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.242 2.628 . . . . 0.0 114.465 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -84.28 51.6 2.13 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 122.199 1.0 . . . . 0.0 112.277 167.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -138.82 -63.04 0.54 Allowed 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 125.456 1.503 . . . . 0.0 107.515 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.79 -34.33 75.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 171.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.1 mt -58.19 -43.49 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 119.194 0.906 . . . . 0.0 113.035 166.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -64.72 -22.32 66.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -58.1 7.17 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-N 119.421 1.01 . . . . 0.0 112.837 170.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.23 14.01 65.01 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -66.97 -48.13 69.46 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 120.097 1.949 . . . . 0.0 114.13 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -112.37 -32.44 6.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.462 1.105 . . . . 0.0 113.805 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.1 mt -80.4 131.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 120.218 1.372 . . . . 0.0 108.411 -171.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -88.18 142.62 27.61 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.273 0.629 . . . . 0.0 112.438 176.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.26 168.5 27.13 Favored Glycine 0 CA--C 1.545 1.944 0 CA-C-O 122.534 1.075 . . . . 0.0 113.345 173.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.8 t -93.1 118.01 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 114.78 -0.71 . . . . 0.0 109.697 -167.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -81.9 104.04 11.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 162.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.48 97.07 7.17 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -168.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.43 133.7 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.8 t -125.19 89.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -91.36 112.12 23.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -87.69 -72.93 0.5 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.368 0.667 . . . . 0.0 110.258 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.1 92.13 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 N-CA-C 107.216 -2.354 . . . . 0.0 107.216 171.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.343 92.2 mttt 77.72 -43.18 0.39 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -163.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -86.47 106.29 17.38 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.406 1.457 . . . . 0.0 109.845 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -88.25 144.93 26.15 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.322 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.36 99.41 4.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 166.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -109.15 172.31 6.92 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.939 0.876 . . . . 0.0 113.047 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 t -141.0 159.71 41.63 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.594 0.712 . . . . 0.0 110.203 166.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mm -123.89 104.49 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 168.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.9 p -100.35 95.82 7.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -87.01 93.45 9.36 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.1 -102.21 1.42 Allowed Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.526 -166.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.0 t -129.64 81.43 2.02 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 160.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -149.63 93.23 2.02 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.28 120.89 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -164.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.1 mt -121.84 88.56 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -94.13 115.73 28.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.884 0.474 . . . . 0.0 109.934 -169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -125.37 161.84 26.12 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.831 0.853 . . . . 0.0 111.481 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.04 142.6 17.5 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.913 0.863 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.19 168.44 23.97 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.128 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.9 m -131.36 133.84 45.71 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.73 134.08 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.86 89.17 Favored Glycine 0 CA--C 1.556 2.622 0 N-CA-C 118.603 2.201 . . . . 0.0 118.603 -167.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -128.7 141.75 51.23 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.291 1.545 . . . . 0.0 108.42 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.36 112.61 9.58 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.106 0.562 . . . . 0.0 111.085 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 85.5 m -125.0 126.04 44.82 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 -169.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.25 112.85 9.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.401 0.68 . . . . 0.0 111.121 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -114.25 121.95 45.25 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -166.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -74.97 100.73 4.22 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.336 0.654 . . . . 0.0 110.054 -177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -84.55 164.67 18.6 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.485 1.136 . . . . 0.0 111.989 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.9 mtm -40.55 -48.37 2.84 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -138.9 108.88 6.33 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.72 -130.48 2.16 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.56 -102.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -140.75 100.92 3.96 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.02 118.67 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 124.323 1.049 . . . . 0.0 110.712 -171.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -79.51 117.63 20.63 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.501 0.667 . . . . 0.0 112.242 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.3 t -142.61 137.78 30.28 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.557 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.34 124.34 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -102.05 101.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -92.79 128.43 38.65 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.561 0.696 . . . . 0.0 109.947 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.9 tp -98.29 123.56 42.45 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.925 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -103.71 123.14 46.48 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.897 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.1 12.59 60.65 Favored Glycine 0 CA--C 1.555 2.533 0 N-CA-C 120.687 3.035 . . . . 0.0 120.687 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.291 5.7 t70 58.36 29.68 18.51 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -169.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.4 -26.22 0.24 Allowed 'General case' 0 CA--C 1.572 1.795 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -118.24 107.09 13.49 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 119.799 1.182 . . . . 0.0 109.389 -171.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.8 mt -86.96 112.54 21.91 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.86 106.43 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 t -146.63 158.77 43.97 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.778 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.7 t -143.19 125.23 15.28 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -82.0 -79.5 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.103 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.06 -88.59 0.42 Allowed 'General case' 0 CA--C 1.561 1.384 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -122.94 59.5 1.06 Allowed 'General case' 0 CA--C 1.567 1.627 0 CA-C-N 119.0 0.818 . . . . 0.0 109.776 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -139.36 102.87 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -87.07 114.27 23.53 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.45 0.643 . . . . 0.0 109.891 177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.6 p -93.58 122.25 35.82 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.827 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.14 98.35 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 m -92.42 81.51 4.89 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -93.67 115.15 27.59 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -87.35 107.39 18.5 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.908 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -103.23 68.78 0.98 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.039 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.46 -92.96 1.61 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.183 0.42 . . . . 0.0 112.182 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -98.53 -43.81 6.72 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.269 0.628 . . . . 0.0 112.126 163.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -80.12 110.31 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.066 0.946 . . . . 0.0 109.39 -165.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -89.95 122.53 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.599 0.76 . . . . 0.0 109.868 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -110.28 102.1 10.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -89.96 105.7 17.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.2 m -98.43 96.91 8.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.5 mtm -95.36 115.71 27.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 173.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -116.64 118.6 33.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.0 tp -75.44 -57.16 4.06 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.533 0.733 . . . . 0.0 111.952 174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.99 -79.02 0.03 OUTLIER Glycine 0 CA--C 1.538 1.488 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.77 -38.46 54.06 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 49.6 mt -88.08 126.06 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 56.1 t -108.66 102.59 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -79.56 142.43 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.92 0.888 . . . . 0.0 109.422 166.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.2 mttm -134.27 131.92 39.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 166.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -101.97 94.8 5.97 Favored 'General case' 0 CA--C 1.556 1.176 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.85 106.71 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -123.28 101.79 7.57 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.497 0.665 . . . . 0.0 111.12 -166.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -86.01 136.99 33.03 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.544 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -72.94 146.46 46.05 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -78.32 -5.55 52.47 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.928 2.566 . . . . 0.0 117.928 -173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.1 m -73.62 116.05 13.75 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 121.56 1.982 . . . . 0.0 111.634 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.94 150.51 5.99 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-O 121.513 0.507 . . . . 0.0 113.035 -176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -84.77 120.3 26.27 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.37 9.4 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -81.99 127.65 33.28 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.366 0.666 . . . . 0.0 109.695 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 tp -62.64 120.76 11.8 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.177 0.513 . . . . 0.0 112.382 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -102.66 -55.23 2.48 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.945 0.898 . . . . 0.0 110.956 -176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.4 m -115.81 105.88 13.2 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.587 0.755 . . . . 0.0 109.365 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.97 102.12 14.2 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.25 115.68 30.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 67.05 69.45 0.39 Allowed 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 124.588 1.155 . . . . 0.0 113.785 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -90.16 -55.03 3.77 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.937 166.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.36 -41.59 98.73 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -47.41 74.94 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 170.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.79 -48.62 63.18 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.5 mmt -62.17 -36.29 81.41 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.52 -40.79 89.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 168.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.01 70.53 Favored 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.8 pt -68.86 -37.67 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 175.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.89 69.91 0.2 Allowed Glycine 0 CA--C 1.543 1.787 0 C-N-CA 123.778 0.704 . . . . 0.0 112.484 -173.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.1 mt -139.41 141.96 30.64 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 167.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.35 160.4 49.68 Favored 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 123.126 2.551 . . . . 0.0 114.288 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -62.73 -22.35 66.47 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -58.26 -55.18 38.38 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 120.076 1.307 . . . . 0.0 113.656 167.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.3 -31.18 72.18 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.3 -58.97 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-N 119.885 1.221 . . . . 0.0 110.904 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -63.89 -22.81 67.09 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -59.35 -57.18 14.12 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.88 1.218 . . . . 0.0 113.507 166.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.88 46.47 1.16 Allowed Glycine 0 N--CA 1.485 1.905 0 N-CA-C 115.832 1.093 . . . . 0.0 115.832 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -61.73 -57.53 11.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -119.49 66.77 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.697 0.76 . . . . 0.0 109.391 164.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.1 mt -131.78 115.26 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 173.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -83.88 128.6 34.66 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.343 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.44 -163.82 31.79 Favored Glycine 0 CA--C 1.546 1.97 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.68 109.74 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.3 t -95.26 99.72 11.63 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.29 0.636 . . . . 0.0 110.492 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.96 99.85 9.39 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.6 mt -87.47 135.81 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.59 101.6 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -86.59 143.04 27.85 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.704 0.764 . . . . 0.0 111.179 171.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -133.47 80.32 1.87 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.6 3.74 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.481 -0.327 . . . . 0.0 112.713 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.56 -22.26 23.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 116.408 2.003 . . . . 0.0 116.408 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.91 111.48 20.27 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.083 1.765 . . . . 0.0 110.541 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -102.64 148.78 25.14 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.47 1.108 . . . . 0.0 110.985 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -146.3 127.46 14.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 167.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -133.24 152.58 51.94 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.325 0.65 . . . . 0.0 111.839 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -139.01 127.44 22.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.8 mm -95.53 98.85 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.6 m -91.76 93.56 8.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.34 168.5 10.08 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.959 0.904 . . . . 0.0 111.664 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.81 63.64 4.43 Favored Glycine 0 CA--C 1.548 2.131 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.8 t -174.11 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.273 1.429 . . . . 0.0 107.757 -173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -143.4 136.78 28.15 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.6 t -89.74 99.38 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 170.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -93.37 100.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -162.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.73 123.73 35.33 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 122.044 0.926 . . . . 0.0 110.462 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.51 139.0 51.68 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.48 -172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -147.63 114.17 5.99 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -125.06 162.78 23.81 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.725 0.774 . . . . 0.0 111.538 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.0 m -124.48 131.01 53.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.02 130.44 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 123.148 0.579 . . . . 0.0 112.401 -174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.79 19.1 79.27 Favored Glycine 0 CA--C 1.554 2.487 0 N-CA-C 118.901 2.321 . . . . 0.0 118.901 -167.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -139.51 140.14 37.11 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.043 1.421 . . . . 0.0 108.226 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.44 102.05 5.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.592 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.2 m -117.74 130.2 56.17 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.534 0.734 . . . . 0.0 109.638 -169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 120.79 19.2 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.0 mt -117.45 127.62 54.2 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.37 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.69 96.29 4.82 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 166.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.6 p -92.76 172.47 8.33 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.463 1.125 . . . . 0.0 112.653 -170.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 14.7 ptp -67.21 96.27 0.46 Allowed 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.196 161.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.304 1.1 p 156.76 -65.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.587 2.355 . . . . 0.0 106.924 -169.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.53 -61.9 0.4 Allowed Glycine 0 N--CA 1.483 1.785 0 CA-C-N 118.851 0.75 . . . . 0.0 113.31 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.73 144.69 47.49 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mtpp -81.45 97.62 7.85 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.977 0.894 . . . . 0.0 108.824 164.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.6 p -111.41 116.32 52.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.173 -161.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -76.91 112.97 14.09 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.385 0.612 . . . . 0.0 111.31 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.2 t -140.47 133.37 29.17 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.248 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.98 120.59 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -103.44 96.18 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -86.26 127.44 34.76 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.249 0.547 . . . . 0.0 110.061 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.2 tp -86.28 118.39 25.7 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.552 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -106.04 140.52 38.89 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.983 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.8 -104.37 1.69 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.316 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -138.97 -45.03 0.47 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.896 0.878 . . . . 0.0 112.842 175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.1 p30 -135.32 53.68 1.96 Allowed 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.588 1.155 . . . . 0.0 111.715 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -149.24 94.85 2.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.9 mt -82.29 150.57 27.18 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.982 0.913 . . . . 0.0 111.393 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.3 t -139.47 113.76 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -172.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.9 t -148.08 164.96 32.26 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.681 0.753 . . . . 0.0 111.217 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -146.48 121.15 9.82 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -128.85 115.06 17.32 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.945 0.898 . . . . 0.0 109.434 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 55.87 54.09 8.54 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 51.34 50.09 19.65 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.98 103.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 103.659 -2.719 . . . . 0.0 103.659 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -80.28 100.52 8.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.1 t -104.65 111.15 23.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.085 0.954 . . . . 0.0 109.006 -169.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -122.74 106.77 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -172.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -98.36 92.05 5.5 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.96 123.6 45.39 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tt -86.78 119.63 27.21 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -108.35 77.5 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.19 -85.09 1.56 Allowed Glycine 0 N--CA 1.485 1.902 0 C-N-CA 123.121 0.391 . . . . 0.0 113.025 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -117.48 -34.31 4.32 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 123.761 0.824 . . . . 0.0 112.859 162.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.4 mp -81.18 118.57 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 124.503 1.121 . . . . 0.0 108.402 -171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.74 118.87 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 123.719 0.808 . . . . 0.0 110.312 -171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.5 m -104.07 115.69 30.88 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.86 106.33 15.44 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 m -95.53 105.98 18.01 Favored 'General case' 0 CA--C 1.556 1.206 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.4 mtm -108.69 109.66 20.89 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.4 m -115.75 121.83 43.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.1 tp -80.25 -62.45 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.794 0.838 . . . . 0.0 110.832 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.71 -80.65 0.03 OUTLIER Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -79.81 -37.17 35.73 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -87.13 122.58 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -170.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.97 104.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -83.18 96.94 8.58 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 168.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -106.61 109.83 21.85 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.08 105.69 15.85 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.4 mp -100.31 106.83 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 m -105.79 107.06 17.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.638 0.775 . . . . 0.0 110.316 -170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -84.4 136.73 33.74 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.845 0.858 . . . . 0.0 110.261 178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -57.73 142.38 45.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.491 1.582 0 C-N-CA 124.37 1.068 . . . . 0.0 112.426 -171.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -78.38 1.86 20.59 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 t -80.74 119.77 23.76 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 121.447 1.93 . . . . 0.0 110.379 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.01 165.4 22.25 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-O 122.146 0.859 . . . . 0.0 113.295 -177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -95.29 113.63 25.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -111.34 95.48 5.54 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -82.25 128.52 34.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.136 0.574 . . . . 0.0 109.724 -174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.5 tp -66.19 115.99 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.578 0.704 . . . . 0.0 112.823 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -81.18 -62.14 1.75 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.66 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.5 t -148.27 124.07 10.57 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.2 pm0 -97.62 146.47 25.27 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-O 121.756 0.788 . . . . 0.0 110.759 170.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -81.34 -55.1 4.94 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -134.31 78.91 1.78 Allowed 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 118.852 0.751 . . . . 0.0 109.211 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.15 -50.18 13.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -60.24 -49.74 76.43 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.64 -44.38 70.73 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.71 -50.54 62.48 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.0 mmt -67.11 -41.46 86.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -59.09 -43.33 91.81 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.58 -42.65 82.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.8 pt -66.94 -42.44 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.39 70.55 0.18 Allowed Glycine 0 CA--C 1.544 1.857 0 CA-C-N 118.955 0.798 . . . . 0.0 114.103 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -112.49 154.79 44.48 Favored Pre-proline 0 CA--C 1.572 1.803 0 C-N-CA 123.891 0.876 . . . . 0.0 110.171 169.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.2 153.52 62.12 Favored 'Trans proline' 0 CA--C 1.561 1.848 0 C-N-CA 122.924 2.416 . . . . 0.0 113.144 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -58.42 -26.29 63.11 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -53.83 -60.31 3.48 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.29 -31.89 66.13 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.46 -59.6 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 CA-C-N 120.169 1.35 . . . . 0.0 111.638 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -73.73 -28.73 61.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -72.47 -44.85 61.75 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 119.347 0.976 . . . . 0.0 113.531 169.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.32 -18.09 76.53 Favored Glycine 0 CA--C 1.551 2.339 0 N-CA-C 119.382 2.513 . . . . 0.0 119.382 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -66.97 -46.8 73.51 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.527 2.164 . . . . 0.0 114.147 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.5 -44.63 78.02 Favored 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 169.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -83.12 106.98 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -75.44 127.85 34.02 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.369 1.068 . . . . 0.0 112.307 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.37 130.36 9.67 Favored Glycine 0 CA--C 1.54 1.639 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.18 110.17 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -96.1 97.48 9.6 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.152 0.581 . . . . 0.0 110.279 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.4 98.25 8.62 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.7 mt -88.47 131.48 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -115.42 94.77 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -84.53 113.64 21.38 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 172.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -95.55 -73.84 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.632 0.773 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.69 91.02 0.1 OUTLIER Glycine 0 N--CA 1.476 1.363 0 N-CA-C 106.995 -2.442 . . . . 0.0 106.995 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.332 61.5 mttm 69.78 -29.59 0.18 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -162.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.8 m80 -87.47 128.19 35.23 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 120.627 1.558 . . . . 0.0 110.449 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -123.86 145.15 49.3 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.818 0.847 . . . . 0.0 110.533 -176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 109.92 5.81 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -122.52 131.32 53.79 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 118.244 0.474 . . . . 0.0 111.977 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.2 m -118.21 127.59 53.89 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.3 mm -110.17 102.72 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.3 m -97.18 77.74 2.71 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.25 98.89 8.51 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.329 0.651 . . . . 0.0 110.701 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.88 -118.51 5.17 Favored Glycine 0 CA--C 1.541 1.661 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.76 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.0 t -112.68 68.25 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.826 0.822 . . . . 0.0 109.252 163.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -157.05 90.29 1.12 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.23 105.39 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.93 94.12 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -165.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -95.03 99.6 11.58 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 -170.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -95.46 149.32 21.52 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -141.06 119.77 12.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -131.01 148.43 52.75 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.254 0.55 . . . . 0.0 110.965 170.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.4 m -125.91 123.32 38.35 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -71.94 133.68 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 123.296 0.638 . . . . 0.0 112.381 -171.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.99 -34.59 4.2 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 117.245 1.658 . . . . 0.0 117.245 -167.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.23 152.9 18.13 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.521 1.129 . . . . 0.0 110.029 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -73.58 127.49 32.9 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.426 0.631 . . . . 0.0 110.652 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.9 m -149.64 144.18 26.0 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.811 0.815 . . . . 0.0 110.065 -174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.54 120.05 21.97 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.394 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.4 mt -94.76 128.75 41.69 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -83.17 99.83 10.18 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 32.9 p -74.53 158.67 33.35 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.777 0.799 . . . . 0.0 111.924 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -54.78 -47.82 73.47 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.9 p -73.41 139.21 45.72 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.191 0.596 . . . . 0.0 110.048 158.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 99.48 0.65 Allowed Glycine 0 CA--C 1.546 1.998 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -133.29 -58.59 0.89 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.722 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.252 12.0 mptt 72.61 84.22 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.169 1.388 . . . . 0.0 109.651 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.14 108.63 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.181 0.593 . . . . 0.0 110.272 -161.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -70.88 112.31 6.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.563 0.745 . . . . 0.0 111.264 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -149.02 136.61 20.36 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.315 -169.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 t -84.78 122.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.66 121.32 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -98.19 124.8 42.94 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.6 tp -92.58 126.42 37.66 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.387 0.613 . . . . 0.0 110.215 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -110.56 119.29 38.7 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.416 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.06 13.97 54.71 Favored Glycine 0 CA--C 1.555 2.59 0 N-CA-C 121.186 3.234 . . . . 0.0 121.186 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.33 7.9 t70 72.89 -6.56 1.65 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -170.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -142.99 29.42 1.49 Allowed 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -156.95 103.53 2.05 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 119.663 1.119 . . . . 0.0 108.389 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.54 140.62 29.6 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.612 0.765 . . . . 0.0 110.333 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 116.78 48.22 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -137.66 100.38 4.19 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 122.748 1.261 . . . . 0.0 108.146 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 t -103.62 122.19 44.48 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.747 -1.569 . . . . 0.0 108.045 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -141.33 171.16 14.45 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.672 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -65.01 122.54 17.26 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.36 1.064 . . . . 0.0 111.304 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.36 74.3 m-20 92.58 -58.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.659 -170.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.3 mt -123.03 123.82 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -163.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -87.39 131.04 34.43 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 161.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -135.98 116.33 13.61 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -166.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.89 116.97 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.374 -1.714 . . . . 0.0 106.374 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.8 m -107.72 94.06 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -103.25 124.26 48.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.46 121.99 28.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -113.12 72.95 0.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.53 -89.04 1.46 Allowed Glycine 0 N--CA 1.485 1.911 0 C-N-CA 123.136 0.398 . . . . 0.0 113.254 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -101.72 -44.23 5.61 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.611 0.764 . . . . 0.0 112.085 162.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.2 mt -79.81 110.7 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 123.797 0.839 . . . . 0.0 109.177 -166.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -89.59 121.24 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 123.841 0.856 . . . . 0.0 108.708 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.3 m -106.84 107.09 17.93 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -103.37 101.8 11.72 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 91.8 m -94.15 98.62 11.1 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.4 mtp -101.17 98.06 8.52 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -104.64 117.5 34.26 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 0.0 109.468 -174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -75.6 -60.43 2.32 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.973 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.22 -82.87 0.04 OUTLIER Glycine 0 N--CA 1.478 1.44 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -78.88 -34.36 44.9 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 165.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.55 121.35 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.8 t -108.21 99.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -85.06 91.73 8.17 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.47 112.87 24.75 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 27.0 mtp-105 -98.15 107.69 20.22 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.96 108.38 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 m -125.19 110.99 14.75 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 122.985 0.514 . . . . 0.0 109.963 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -83.66 134.55 34.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.415 -0.803 . . . . 0.0 111.668 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -73.18 137.95 45.38 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.282 0.633 . . . . 0.0 112.311 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 172.445 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -76.85 -16.87 59.29 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -62.59 115.16 4.03 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 121.759 2.072 . . . . 0.0 113.188 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.11 157.26 10.4 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 121.847 0.693 . . . . 0.0 114.501 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -88.96 121.61 31.48 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.315 0.646 . . . . 0.0 110.008 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -117.55 105.94 12.61 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -78.22 126.91 31.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.34 136.37 49.66 Favored 'General case' 0 CA--C 1.558 1.253 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.857 173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -112.8 -62.23 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.845 0.858 . . . . 0.0 110.86 172.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.9 t -120.15 140.86 50.48 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 119.406 1.003 . . . . 0.0 111.569 -168.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.427 HE22 ' HG2' ' A' ' 122' ' ' ARG . 1.8 mm-40 -116.45 129.12 56.04 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.719 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.92 -64.69 1.12 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 118.623 -0.703 . . . . 0.0 112.143 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -128.31 72.59 1.43 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.918 0.781 . . . . 0.0 109.312 176.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.91 -57.05 4.11 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.063 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.07 -35.13 79.17 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.29 84.87 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -70.35 -50.39 39.51 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 119.595 1.089 . . . . 0.0 113.756 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.6 mmt -68.36 -38.42 81.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -66.27 -42.85 87.88 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 166.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.11 89.88 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.853 2.168 . . . . 0.0 116.853 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.6 pt -61.9 -43.86 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.15 73.05 0.18 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.796 0.712 . . . . 0.0 112.197 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -133.07 148.37 69.05 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 123.494 0.718 . . . . 0.0 110.965 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.92 165.87 27.76 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 123.11 2.54 . . . . 0.0 113.915 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -56.79 -34.33 67.53 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 116.15 1.907 . . . . 0.0 116.15 171.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -50.31 -54.15 23.49 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 170.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 mt -77.15 -37.76 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.0 mt -68.29 -61.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 124.328 1.051 . . . . 0.0 110.601 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -64.88 -23.89 67.37 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -71.1 -45.5 63.55 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 166.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.6 -7.17 78.98 Favored Glycine 0 CA--C 1.553 2.447 0 N-CA-C 120.074 2.79 . . . . 0.0 120.074 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -71.3 -49.34 43.73 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 120.778 2.289 . . . . 0.0 114.296 172.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.22 -48.22 44.56 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.458 0.703 . . . . 0.0 112.893 171.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.51 97.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -98.05 125.86 43.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 0.0 110.397 -169.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -79.46 149.02 31.52 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.018 1.567 . . . . 0.0 117.018 -161.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.65 116.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.6 t -85.11 103.53 14.19 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -104.26 99.71 9.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -172.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.9 mt -87.05 126.73 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.93 97.29 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 165.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.26 117.38 33.6 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -133.1 81.86 1.96 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.08 0.952 . . . . 0.0 109.941 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.95 76.95 0.18 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.296 90.4 mttt 71.55 -33.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 -163.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -84.65 107.37 16.82 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 120.157 1.344 . . . . 0.0 110.762 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -94.35 150.17 20.54 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 122.594 1.187 . . . . 0.0 111.325 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -154.91 134.88 12.96 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.177 157.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -134.16 117.75 16.89 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.972 0.509 . . . . 0.0 109.69 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.7 m -105.7 107.62 18.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.79 110.63 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.9 m -110.99 93.55 4.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.07 -142.59 0.29 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.452 0.701 . . . . 0.0 111.092 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.35 -85.09 0.47 Allowed Glycine 0 N--CA 1.484 1.85 0 O-C-N 121.309 -0.869 . . . . 0.0 112.294 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 t -112.91 56.05 0.68 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.947 0.403 . . . . 0.0 111.592 162.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -145.93 90.22 1.96 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 161.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.4 92.14 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.24 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -167.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -103.67 120.57 41.18 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.463 0.649 . . . . 0.0 110.166 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -110.63 148.34 32.41 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.592 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.17 117.41 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.852 0.461 . . . . 0.0 109.789 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -142.07 176.1 9.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.098 0.952 . . . . 0.0 112.679 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -139.17 133.63 31.68 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 168.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -66.9 131.58 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 C-N-CA 123.201 0.6 . . . . 0.0 112.518 -177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.82 -32.21 5.2 Favored Glycine 0 CA--C 1.553 2.436 0 N-CA-C 117.813 1.885 . . . . 0.0 117.813 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -98.75 144.23 28.22 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.4 1.1 . . . . 0.0 109.998 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.6 109.74 11.82 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 120.994 0.425 . . . . 0.0 110.382 174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.3 m -137.15 142.0 42.23 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.383 0.673 . . . . 0.0 110.276 -167.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -68.45 125.94 28.07 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -165.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.36 119.5 39.4 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -74.17 98.05 3.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.251 0.62 . . . . 0.0 109.658 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -74.97 159.7 31.47 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.909 0.862 . . . . 0.0 111.591 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.31 -51.21 35.5 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 176.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -124.72 126.5 45.77 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 168.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.15 -93.56 0.85 Allowed Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.064 0.786 . . . . 0.0 115.064 164.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -101.75 145.27 29.36 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 122.173 0.987 . . . . 0.0 113.025 -153.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.3 95.8 7.3 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 166.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.06 113.72 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.265 -148.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.05 102.91 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.473 0.654 . . . . 0.0 111.292 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.4 p -142.58 131.39 22.82 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -165.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 37.1 t -72.21 126.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.36 96.23 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -93.06 116.47 29.08 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.26 118.37 17.14 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 121.693 0.759 . . . . 0.0 110.536 -178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.03 134.33 45.43 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.837 -176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -100.54 1.05 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-N 114.013 -1.448 . . . . 0.0 113.315 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.35 -41.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.99 0.916 . . . . 0.0 113.319 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -143.97 57.06 1.34 Allowed 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 124.212 1.005 . . . . 0.0 112.38 -171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -148.36 105.12 3.58 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.3 112.79 24.85 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.75 116.19 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.2 t -145.61 146.19 31.26 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.787 0.803 . . . . 0.0 109.844 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 t -144.94 126.64 15.22 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.258 0.3 OUTLIER -93.65 -85.35 0.28 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -169.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -106.39 -82.11 0.54 Allowed 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -122.69 60.67 1.01 Allowed 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.611 0.764 . . . . 0.0 109.683 163.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.78 95.81 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -85.42 94.11 8.9 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.801 0.84 . . . . 0.0 109.548 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.2 t -99.52 109.84 22.34 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.75 103.62 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.2 m -100.86 87.75 3.39 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.54 120.83 38.63 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.116 0.567 . . . . 0.0 109.816 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.43 134.56 38.36 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.235 0.54 . . . . 0.0 110.482 171.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -130.14 65.25 1.51 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.812 0.845 . . . . 0.0 109.047 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.43 -91.94 1.07 Allowed Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.761 -0.587 . . . . 0.0 113.162 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.65 -36.37 12.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 166.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.5 mm -80.46 109.08 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 120.061 1.3 . . . . 0.0 109.346 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.29 108.77 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 167.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.9 m -102.71 97.24 7.44 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -171.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -92.69 99.92 12.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.1 m -95.22 96.05 8.93 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.4 ttm -102.34 115.67 31.05 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.7 m -117.43 123.5 46.54 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.2 tp -78.41 -93.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.13 -69.58 1.22 Allowed Glycine 0 N--CA 1.481 1.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 163.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -144.44 65.68 1.28 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 166.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 86.3 mt -123.83 106.79 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 172.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.88 87.64 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -84.72 100.53 11.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.646 0.778 . . . . 0.0 109.254 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.38 126.46 52.14 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.234 0.614 . . . . 0.0 109.401 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HG2' HE22 ' A' ' 12' ' ' GLN . 32.7 mtp-105 -104.93 109.7 21.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.2 mp -93.82 96.28 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.7 m -123.21 97.62 5.5 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.351 0.596 . . . . 0.0 110.879 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -82.62 145.84 29.46 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.983 0.913 . . . . 0.0 111.759 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -71.15 127.49 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 120.94 0.4 . . . . 0.0 111.492 166.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -177.259 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -80.58 -15.0 57.72 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.3 t -69.44 124.25 23.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 121.163 1.801 . . . . 0.0 113.156 -171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.63 172.49 20.5 Favored Glycine 0 CA--C 1.546 2.021 0 CA-C-O 122.306 0.948 . . . . 0.0 113.801 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -93.27 126.86 38.61 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.554 -0.823 . . . . 0.0 108.965 169.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -125.51 97.62 5.26 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.13 125.56 27.13 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.287 0.635 . . . . 0.0 110.251 177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.7 134.28 52.87 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.956 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -97.27 -57.2 2.32 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.904 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -140.88 134.76 30.53 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.684 0.794 . . . . 0.0 109.935 -174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -99.28 124.39 44.33 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.455 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 9.9 tp10 -75.52 -63.04 1.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.323 178.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -134.43 71.34 1.45 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 118.618 0.645 . . . . 0.0 109.712 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.27 -41.41 70.07 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -68.79 -49.89 54.85 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.844 1.202 . . . . 0.0 114.243 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.3 -44.25 84.0 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -66.58 -51.05 60.71 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.3 mmt -63.43 -35.12 79.38 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -69.38 -39.22 78.14 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -39.3 93.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -65.51 -39.52 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.73 46.62 0.11 Allowed Glycine 0 CA--C 1.545 1.957 0 N-CA-C 116.625 1.41 . . . . 0.0 116.625 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -99.69 152.73 37.9 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-N 118.968 1.384 . . . . 0.0 111.698 174.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.44 161.66 39.68 Favored 'Trans proline' 0 CA--C 1.561 1.853 0 C-N-CA 123.22 2.613 . . . . 0.0 114.201 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -60.08 -25.48 65.44 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -61.25 -56.46 20.37 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.783 1.174 . . . . 0.0 113.83 172.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -71.99 -26.1 62.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mt -74.98 -54.85 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.425 1.011 . . . . 0.0 110.796 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -71.92 -28.02 63.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.721 1.748 . . . . 0.0 115.721 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.5 -42.74 67.65 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.601 1.091 . . . . 0.0 113.868 166.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.14 1.53 87.65 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 119.51 2.564 . . . . 0.0 119.51 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -73.14 -49.0 30.73 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 120.465 2.133 . . . . 0.0 114.02 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -68.31 -40.58 81.67 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 171.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.6 mt -84.47 102.19 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.96 137.19 32.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.668 0.787 . . . . 0.0 111.502 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.8 -172.56 33.02 Favored Glycine 0 CA--C 1.546 2.023 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 -170.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.6 t -138.39 115.45 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -83.86 98.1 9.56 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.384 0.612 . . . . 0.0 110.03 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.13 91.13 5.41 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.9 mt -93.45 131.37 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -109.01 93.51 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 167.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.95 106.39 18.71 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 178.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.34 82.78 1.95 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.29 -105.13 1.57 Allowed Glycine 0 CA--C 1.543 1.805 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.848 -173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.54 -28.85 21.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 171.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -84.69 107.25 16.79 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 120.699 1.59 . . . . 0.0 110.848 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -93.89 144.2 25.66 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.898 174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -144.14 88.32 1.95 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -95.57 122.18 38.05 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.803 0.441 . . . . 0.0 111.139 -176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.4 m -115.55 102.84 10.15 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -83.98 105.93 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.5 m -105.1 84.79 2.17 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.21 156.89 17.17 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.547 0.739 . . . . 0.0 111.321 173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.31 -45.64 64.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.296 2.078 . . . . 0.0 118.296 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.2 m -67.8 -51.8 44.55 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.62 119.27 9.78 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.581 1.082 . . . . 0.0 109.689 -170.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.94 99.58 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.24 105.71 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -98.24 121.71 40.51 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.58 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -122.77 157.25 32.79 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.826 0.85 . . . . 0.0 110.603 -170.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -152.09 117.74 5.39 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -126.23 159.36 33.26 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.632 0.729 . . . . 0.0 110.562 168.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.8 m -116.8 140.66 49.18 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 163.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 m -72.52 130.06 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.298 0.57 . . . . 0.0 111.79 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.39 29.06 64.62 Favored Glycine 0 CA--C 1.557 2.679 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -164.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -144.29 128.54 17.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -74.99 100.13 4.06 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.471 0.708 . . . . 0.0 111.776 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -112.31 139.48 47.82 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.428 0.633 . . . . 0.0 109.777 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.92 105.37 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.591 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.94 118.13 36.14 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 -168.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.7 111.25 8.66 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -174.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.0 t -78.84 153.61 30.5 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.253 0.621 . . . . 0.0 111.38 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.252 1.6 pmm? -55.25 -41.49 72.24 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.271 12.9 t -61.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.6 103.52 0.51 Allowed Glycine 0 N--CA 1.479 1.565 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -150.87 -59.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.928 0.491 . . . . 0.0 111.887 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.298 38.0 mtpt 69.92 81.25 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 124.744 1.218 . . . . 0.0 110.316 -163.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -111.66 115.82 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.4 -161.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -78.57 114.78 17.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 0.0 112.135 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -145.94 137.67 25.05 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.644 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.7 t -80.76 128.74 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.67 108.11 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.1 116.39 29.79 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 147.04 41.68 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-O 121.629 0.728 . . . . 0.0 111.852 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -113.75 120.27 40.23 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.58 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.94 -103.4 2.67 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.669 -178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.83 -50.51 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.78 0.832 . . . . 0.0 111.902 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -108.28 37.03 2.59 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -147.52 116.64 6.88 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.54 144.82 26.85 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.014 0.926 . . . . 0.0 109.967 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.8 t -132.81 113.79 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.5 t -142.89 169.14 18.13 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 122.555 1.169 . . . . 0.0 110.223 167.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -147.81 121.33 9.12 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -83.02 -86.0 0.11 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.564 -169.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -105.78 -88.19 0.45 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -117.89 59.56 0.79 Allowed 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 119.168 0.895 . . . . 0.0 109.678 158.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.4 108.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 104.033 -2.58 . . . . 0.0 104.033 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -81.4 124.48 29.44 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.725 0.774 . . . . 0.0 109.29 168.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' SD ' ' A' ' 113' ' ' MET . 23.7 p -120.88 114.16 21.17 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 113.943 -1.48 . . . . 0.0 108.491 -170.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.2 t -121.88 106.49 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 m -97.39 89.95 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -104.67 122.7 46.2 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.3 tt -92.42 113.48 25.76 Favored 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -109.52 72.0 0.79 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 123.64 0.776 . . . . 0.0 110.148 -172.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.62 74.85 0.46 Allowed Glycine 0 N--CA 1.487 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 114.384 -174.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.253 20.9 m-20 55.67 25.75 8.52 Favored 'General case' 0 CA--C 1.574 1.869 0 N-CA-C 117.624 2.453 . . . . 0.0 117.624 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.9 mt -129.6 93.68 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 24.1 mt -77.49 115.85 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.8 m -120.55 98.5 6.06 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -95.3 104.62 16.52 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.6 m -95.24 93.98 7.62 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.4 ' SD ' ' HB3' ' A' ' 100' ' ' SER . 2.2 mmm -104.94 110.97 23.57 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.2 t -115.96 125.43 52.52 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.342 -172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.9 tp -112.75 99.09 7.65 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 168.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.66 -110.09 3.08 Favored Glycine 0 CA--C 1.544 1.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 114.277 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.28 -33.89 28.93 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 173.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.58 122.14 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.125 0.97 . . . . 0.0 108.562 -172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.3 t -108.89 100.35 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -82.37 118.69 23.37 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 7.6 ttpm? -129.32 109.3 10.99 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -177.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -99.4 95.76 7.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.016 0.526 . . . . 0.0 110.652 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.24 112.98 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.6 m -105.8 176.87 5.02 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.979 0.895 . . . . 0.0 112.206 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -143.93 142.65 30.87 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 105.44 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.192 0.597 . . . . 0.0 111.046 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 -179.017 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 120.987 0.422 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -81.08 3.21 24.1 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.7 p -77.66 112.38 14.42 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 121.495 1.952 . . . . 0.0 111.949 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.96 171.25 35.28 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 122.681 1.156 . . . . 0.0 113.861 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.91 125.57 44.37 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.22 96.59 5.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -172.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.28 121.28 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.714 0.806 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 tp -65.37 130.22 42.53 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.673 0.749 . . . . 0.0 111.736 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.0 -51.01 2.85 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.595 -168.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.1 p -145.41 120.59 10.15 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.623 0.769 . . . . 0.0 109.046 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -108.1 102.88 12.0 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -84.37 134.7 34.48 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.657 0.742 . . . . 0.0 110.1 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 52.45 55.62 8.85 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -169.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -72.87 -62.48 1.44 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.097 164.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -70.87 -34.64 71.82 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.77 91.09 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 165.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -72.38 -52.0 18.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.0 -42.06 99.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -65.9 -36.43 83.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.42 -43.51 90.28 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 171.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -71.77 -32.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 171.35 -53.46 0.18 Allowed Glycine 0 N--CA 1.484 1.857 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 -171.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.61 145.02 78.51 Favored Pre-proline 0 CA--C 1.575 1.935 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 -164.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.26 165.51 27.67 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 113.663 172.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -58.63 -31.47 68.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -57.93 -54.49 46.35 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.3 mt -71.71 -36.09 70.41 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.39 -56.95 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 124.277 1.031 . . . . 0.0 112.134 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -59.61 -31.31 69.37 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -89.1 70.73 8.42 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.384 0.993 . . . . 0.0 110.125 161.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.55 -35.95 0.14 Allowed Glycine 0 CA--C 1.547 2.09 0 N-CA-C 115.729 1.052 . . . . 0.0 115.729 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.01 -45.14 93.75 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -114.98 51.85 0.89 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.448 1.022 . . . . 0.0 111.781 163.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.8 mt -128.05 93.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 164.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -97.03 117.32 30.94 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -164.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.55 140.48 18.15 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 115.648 1.019 . . . . 0.0 115.648 -169.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -81.37 115.1 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 173.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.1 t -81.53 106.11 13.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 172.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -96.51 87.82 4.51 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mt -88.78 123.71 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 -173.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.98 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.93 115.65 28.56 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -133.63 98.43 4.2 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.08 -121.63 10.6 Favored Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.242 0.449 . . . . 0.0 113.532 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -80.68 -24.88 38.58 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -79.33 141.11 37.26 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.685 1.584 . . . . 0.0 112.427 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -135.33 144.5 46.73 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.404 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -146.55 104.87 3.79 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -108.83 132.35 54.1 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.16 0.584 . . . . 0.0 111.528 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -128.98 109.58 11.34 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -100.31 124.84 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 78.2 p -92.8 61.03 3.51 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 122.959 0.503 . . . . 0.0 112.191 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.37 115.15 27.71 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.357 -0.839 . . . . 0.0 110.91 -173.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.39 -132.79 13.72 Favored Glycine 0 CA--C 1.541 1.698 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.774 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 t -78.09 -30.85 49.81 Favored 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 165.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.27 126.45 33.71 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.258 0.936 . . . . 0.0 110.6 -171.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -97.42 99.06 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 170.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -93.15 101.53 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -165.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -88.78 124.13 33.86 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.84 0.829 . . . . 0.0 110.303 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -127.65 146.62 50.49 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.935 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -146.26 121.82 10.42 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -129.4 166.73 18.97 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.167 0.984 . . . . 0.0 111.718 170.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.3 m -135.67 130.19 33.91 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -70.68 131.48 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.3 0.572 . . . . 0.0 112.332 -173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.87 20.08 79.63 Favored Glycine 0 CA--C 1.553 2.449 0 N-CA-C 118.468 2.147 . . . . 0.0 118.468 -166.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -142.87 138.34 30.19 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 119.064 1.432 . . . . 0.0 107.919 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 103.95 8.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.05 139.78 53.12 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 122.055 0.931 . . . . 0.0 110.896 -166.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.62 121.82 22.2 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.074 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -121.04 113.42 20.03 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -172.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -83.47 99.22 9.97 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.7 p -94.14 171.87 8.57 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.172 0.987 . . . . 0.0 111.762 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -36.26 41.46 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -134.54 140.92 46.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 119.46 1.027 . . . . 0.0 110.144 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.61 -118.97 4.01 Favored Glycine 0 N--CA 1.479 1.544 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.43 173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.84 -89.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -155.97 98.68 1.91 Allowed 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.25 113.98 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.112 0.965 . . . . 0.0 111.23 -172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -92.21 113.05 25.22 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.378 0.671 . . . . 0.0 111.358 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -143.17 146.6 33.85 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.96 0.886 . . . . 0.0 110.354 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.71 135.39 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 124.019 0.928 . . . . 0.0 109.076 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -113.81 109.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -90.5 124.91 35.38 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.326 0.584 . . . . 0.0 110.107 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -89.04 120.17 30.21 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.51 126.34 52.44 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.941 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.82 -108.43 3.39 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.968 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.38 -51.01 0.43 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.699 0.799 . . . . 0.0 112.313 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -129.62 53.35 1.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 124.308 1.043 . . . . 0.0 112.068 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -147.88 101.12 3.28 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -82.65 152.02 26.04 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.697 0.799 . . . . 0.0 111.416 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.68 116.72 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -153.08 116.75 4.73 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.905 0.859 . . . . 0.0 109.713 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.4 t -89.14 126.35 35.43 Favored 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.327 163.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.65 -78.15 0.27 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.41 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -107.56 -80.81 0.56 Allowed 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -130.1 62.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 163.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.3 mt -139.4 97.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -81.88 98.76 8.68 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.2 m -100.22 108.89 21.09 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.668 -169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.11 105.73 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 m -102.06 90.75 4.06 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -100.16 120.06 39.3 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.475 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.44 115.54 18.22 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -109.59 71.06 0.75 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.7 -88.88 1.47 Allowed Glycine 0 N--CA 1.484 1.849 0 O-C-N 122.137 -0.352 . . . . 0.0 112.724 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.59 -48.72 4.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.428 0.691 . . . . 0.0 111.496 160.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.52 111.01 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.666 0.787 . . . . 0.0 109.808 -160.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.7 tt -86.96 123.96 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.771 0.828 . . . . 0.0 109.402 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.4 m -115.61 101.03 8.49 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -93.66 104.37 16.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.866 0.866 . . . . 0.0 108.773 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.0 m -103.06 101.04 11.0 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.09 105.42 15.59 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.396 0.678 . . . . 0.0 109.536 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.4 m -100.42 112.13 24.46 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -70.23 -62.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.742 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.46 -81.32 0.03 OUTLIER Glycine 0 CA--C 1.536 1.395 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 171.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -81.89 -30.93 31.72 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 165.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -84.35 124.31 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.473 1.033 . . . . 0.0 108.27 -173.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.2 t -111.52 103.57 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -87.09 95.22 9.87 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.939 0.895 . . . . 0.0 110.142 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -98.68 121.17 40.28 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.171 0.588 . . . . 0.0 109.473 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -108.58 109.25 20.42 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.89 105.89 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 -176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.0 m -122.53 109.13 13.94 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.133 0.573 . . . . 0.0 110.56 -167.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -77.37 128.39 34.2 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.544 0.737 . . . . 0.0 112.21 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -78.09 133.7 37.84 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.36 0.664 . . . . 0.0 110.72 174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.86 -0.59 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.271 81.7 m-85 63.43 -2.35 0.48 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 120.206 3.41 . . . . 0.0 120.206 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.7 p -90.62 110.04 21.2 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 120.938 1.699 . . . . 0.0 110.421 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.1 173.85 39.78 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-O 122.768 1.204 . . . . 0.0 114.193 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -105.63 100.05 9.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -105.19 99.06 8.68 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -168.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -86.8 130.68 34.37 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.791 0.436 . . . . 0.0 110.507 -170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.39 115.61 4.76 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.634 0.73 . . . . 0.0 112.293 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.78 -57.28 3.18 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.34 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 t -148.02 136.35 21.41 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.2 0.909 . . . . 0.0 110.317 -173.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -91.3 136.63 32.97 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.716 166.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.18 -61.91 1.73 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 118.589 -0.719 . . . . 0.0 112.067 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -129.43 64.99 1.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.591 0.632 . . . . 0.0 110.324 -173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.4 -47.34 50.06 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -64.11 -46.88 82.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.62 -46.53 69.0 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.277 1.955 . . . . 0.0 116.277 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.93 -50.16 63.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 119.504 1.047 . . . . 0.0 113.517 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 19.7 mmt -63.45 -40.41 97.07 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -64.86 -42.72 94.63 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.04 73.92 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.49 -42.65 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.57 65.59 0.08 OUTLIER Glycine 0 N--CA 1.479 1.504 0 C-N-CA 123.961 0.791 . . . . 0.0 112.457 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.58 142.47 44.97 Favored Pre-proline 0 CA--C 1.566 1.576 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.138 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.97 168.61 24.27 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 123.011 2.474 . . . . 0.0 114.305 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -59.58 -27.59 66.41 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -56.57 -46.49 80.74 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -76.97 -42.22 39.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.1 mt -68.27 -61.33 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 124.244 1.017 . . . . 0.0 111.138 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -77.97 -53.33 7.55 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 120.444 1.474 . . . . 0.0 112.764 163.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.87 -68.5 1.62 Allowed Glycine 0 N--CA 1.481 1.675 0 CA-C-N 118.878 0.763 . . . . 0.0 114.872 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 67.03 66.53 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.062 0.945 . . . . 0.0 112.491 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 64.15 80.06 0.24 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.473 1.109 . . . . 0.0 111.933 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.59 110.35 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -84.74 105.23 15.37 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.452 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.5 171.24 25.91 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 122.578 1.099 . . . . 0.0 113.323 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.98 118.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 114.743 -0.728 . . . . 0.0 109.503 -167.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.7 m -94.92 98.07 10.44 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.36 99.54 12.04 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.437 -170.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mt -92.57 123.79 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -116.94 96.62 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -88.8 128.03 35.63 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -121.45 76.86 1.28 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.41 -100.79 1.2 Allowed Glycine 0 CA--C 1.544 1.898 0 C-N-CA 123.089 0.376 . . . . 0.0 112.572 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -89.4 -17.35 28.95 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -92.96 102.79 15.15 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 120.662 1.574 . . . . 0.0 110.798 -166.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.95 146.0 23.95 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.892 0.877 . . . . 0.0 112.175 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.6 100.9 3.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -113.94 133.47 55.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.58 0.752 . . . . 0.0 112.075 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -125.83 90.57 3.23 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -91.97 132.62 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -87.58 105.92 17.65 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 165.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -137.19 110.86 8.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.13 -150.71 37.65 Favored Glycine 0 CA--C 1.545 1.953 0 CA-C-O 121.65 0.583 . . . . 0.0 113.586 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.0 m -67.44 -23.88 65.57 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 174.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.43 147.7 34.7 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 119.437 1.017 . . . . 0.0 111.303 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.3 t -90.83 109.54 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -89.18 103.26 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -100.54 114.29 27.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.359 0.599 . . . . 0.0 109.4 -173.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -119.62 148.22 43.6 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.84 -172.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -145.3 123.47 12.18 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -134.53 172.42 12.95 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.178 0.99 . . . . 0.0 111.256 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.9 m -133.16 133.24 42.59 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.87 127.6 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.354 0.661 . . . . 0.0 111.513 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.42 32.41 59.89 Favored Glycine 0 CA--C 1.552 2.358 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -164.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -148.6 136.79 21.06 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.11 102.64 3.62 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.383 0.673 . . . . 0.0 110.912 175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 71.5 m -136.74 142.64 43.06 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.621 0.768 . . . . 0.0 110.318 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -67.48 138.89 56.94 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -173.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.5 mt -121.47 122.54 39.98 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.5 107.23 9.8 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 m -73.44 154.41 39.98 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.317 0.58 . . . . 0.0 110.484 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -53.28 -46.39 69.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 62.3 m -75.11 115.7 15.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 152.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.34 98.58 0.2 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 116.672 1.429 . . . . 0.0 116.672 -161.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -143.77 116.3 8.62 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -92.49 89.34 6.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.24 108.99 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.439 -160.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.74 114.34 13.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.632 0.773 . . . . 0.0 111.555 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 t -143.6 137.79 28.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.912 -169.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 36.2 t -81.87 116.08 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.57 109.29 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -93.25 126.97 38.64 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.543 0.687 . . . . 0.0 110.255 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.2 tp -93.33 120.0 33.11 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.298 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.73 122.52 35.21 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.811 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.8 -105.45 1.95 Allowed Glycine 0 CA--C 1.541 1.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.495 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -135.45 -38.83 0.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -134.19 47.75 2.39 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -151.04 97.55 2.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.612 -0.68 . . . . 0.0 109.419 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.8 mt -82.65 151.98 26.05 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.659 0.784 . . . . 0.0 111.577 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.54 118.53 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 t -154.14 116.49 4.33 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.617 0.723 . . . . 0.0 109.428 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.5 t -105.0 126.09 51.68 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.215 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -137.32 116.98 12.98 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -172.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.322 36.1 mtmm 70.58 -96.89 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.798 1.239 . . . . 0.0 109.814 -172.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -142.24 62.31 1.43 Allowed 'General case' 0 CA--C 1.565 1.535 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 159.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.2 mp -132.52 98.35 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 103.22 -2.882 . . . . 0.0 103.22 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.86 95.75 8.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.9 t -104.67 114.19 28.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.505 0.722 . . . . 0.0 110.082 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.4 t -117.88 113.02 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.4 m -100.61 90.95 4.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -101.19 125.12 47.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tt -85.8 113.77 22.22 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -103.24 76.29 1.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.76 -83.43 1.63 Allowed Glycine 0 N--CA 1.483 1.822 0 CA-C-N 116.484 -0.325 . . . . 0.0 112.718 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -118.53 -34.93 3.87 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.834 0.854 . . . . 0.0 113.063 164.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.1 mp -81.15 116.19 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.422 1.089 . . . . 0.0 108.265 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.3 123.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.546 0.738 . . . . 0.0 109.721 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.6 m -112.92 109.72 19.34 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -101.96 100.23 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.2 m -99.21 108.78 21.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.6 mtt -108.46 104.48 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.249 0.62 . . . . 0.0 109.356 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.8 m -93.18 118.17 30.92 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.8 tp -82.35 -94.76 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.12 -74.46 1.25 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 165.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.94 61.01 1.68 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.297 0.57 . . . . 0.0 109.537 160.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.73 106.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 171.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.81 94.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -83.69 87.51 7.05 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.61 0.764 . . . . 0.0 109.521 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -86.14 111.43 20.36 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -105.48 95.14 5.62 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -84.63 121.79 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 m -130.3 101.6 5.84 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.52 0.676 . . . . 0.0 110.019 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 129.57 36.74 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.599 1.16 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -66.39 158.53 29.06 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -173.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 167.041 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.85 -13.24 59.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 118.048 2.61 . . . . 0.0 118.048 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 107.16 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.639 2.018 . . . . 0.0 112.487 -166.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.91 162.67 20.34 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-O 122.638 1.132 . . . . 0.0 113.932 -173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -82.96 133.98 35.08 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 114.049 -1.075 . . . . 0.0 110.496 173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -133.29 102.17 5.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -84.51 137.65 33.22 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.886 0.85 . . . . 0.0 110.653 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.4 tp -69.83 126.56 30.06 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.297 -175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -102.48 -63.2 1.18 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.0 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.6 t -130.0 118.34 21.45 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.81 0.844 . . . . 0.0 108.734 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.11 103.28 12.79 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.835 0.854 . . . . 0.0 109.245 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -75.83 127.98 34.16 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.319 1.048 . . . . 0.0 110.078 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.25 68.0 m-20 66.14 41.22 3.6 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -67.92 -48.26 66.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.78 -1.2 . . . . 0.0 113.629 172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.17 -43.84 98.25 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.08 -49.17 62.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 174.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -70.44 -45.99 64.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.55 -39.02 93.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -62.36 -39.63 93.78 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.44 -45.66 71.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.2 pt -67.29 -37.19 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.7 60.64 0.13 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 115.106 0.802 . . . . 0.0 115.106 172.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.25 148.44 37.56 Favored Pre-proline 0 CA--C 1.571 1.754 0 CA-C-N 117.601 0.7 . . . . 0.0 109.732 168.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.95 152.63 73.39 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.788 2.325 . . . . 0.0 113.074 165.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.53 -22.21 66.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.7 -50.45 72.39 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.87 -25.99 62.17 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.2 mt -66.81 -53.6 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-N 120.264 1.393 . . . . 0.0 111.903 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -68.71 -39.29 80.54 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -85.06 73.91 10.59 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.511 1.051 . . . . 0.0 109.224 161.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.34 -46.67 0.13 Allowed Glycine 0 CA--C 1.546 2.017 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.08 -167.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -60.46 -47.77 84.66 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -100.91 44.18 1.02 Allowed 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 168.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.3 mt -125.86 111.26 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.44 99.98 5.84 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -173.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.49 -165.85 18.19 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-O 122.325 0.958 . . . . 0.0 114.145 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.03 114.71 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-N 114.503 -0.848 . . . . 0.0 108.732 -164.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -87.15 101.03 13.1 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 165.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.8 103.56 14.29 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.3 mt -86.01 127.81 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.1 t -114.03 92.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.37 118.29 34.69 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.575 0.75 . . . . 0.0 109.404 -174.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -130.7 87.04 2.44 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.47 -121.97 13.91 Favored Glycine 0 CA--C 1.547 2.046 0 C-N-CA 123.313 0.482 . . . . 0.0 113.399 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -78.73 -12.66 60.03 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -94.2 126.64 39.57 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 120.302 1.41 . . . . 0.0 110.139 -172.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -126.67 147.67 49.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.594 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.32 119.0 10.45 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 162.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -110.67 110.82 21.64 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.5 m -113.35 107.52 15.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -170.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.78 96.32 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -97.4 97.89 9.49 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.09 88.16 2.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.359 0.664 . . . . 0.0 109.406 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.28 -111.8 3.86 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 123.337 0.494 . . . . 0.0 114.273 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 t -73.03 -40.98 64.69 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -83.66 104.4 13.75 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 118.922 0.783 . . . . 0.0 110.786 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.27 96.36 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 171.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.05 93.33 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -167.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -100.97 111.32 23.5 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -131.3 137.05 48.65 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -137.42 116.56 12.55 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -122.16 166.59 14.34 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 122.295 1.045 . . . . 0.0 111.207 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.3 m -132.17 129.82 40.27 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.2 m -71.05 130.1 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.268 0.556 . . . . 0.0 111.769 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.91 16.84 73.98 Favored Glycine 0 CA--C 1.556 2.619 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -163.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -138.29 141.29 39.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 119.142 1.471 . . . . 0.0 107.916 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.88 122.11 21.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.927 -0.483 . . . . 0.0 110.684 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 76.8 m -128.77 124.89 36.64 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -170.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -86.87 109.61 19.42 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.073 0.549 . . . . 0.0 110.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.6 mt -120.84 114.37 21.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -162.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.15 98.9 9.59 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.31 0.576 . . . . 0.0 110.534 -173.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 60.3 p -71.07 179.02 2.95 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.445 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptp -53.81 -42.18 68.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -78.95 129.64 34.72 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 119.508 1.049 . . . . 0.0 109.288 154.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.12 107.77 2.27 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 114.112 0.405 . . . . 0.0 114.112 -173.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.252 13.4 pt-20 -136.64 -50.44 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.721 0.809 . . . . 0.0 113.126 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.316 31.4 ttmt 67.67 82.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.266 1.426 . . . . 0.0 111.802 -176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.85 119.7 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.055 -158.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -74.72 119.63 19.17 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.916 0.887 . . . . 0.0 112.137 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.5 t -152.26 134.68 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.587 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -77.8 126.68 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.0 t -98.66 113.25 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -98.97 131.13 45.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.476 0.71 . . . . 0.0 110.362 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 tp -107.22 125.54 51.25 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.604 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -105.22 121.45 43.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.685 170.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.07 11.99 67.8 Favored Glycine 0 CA--C 1.553 2.407 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.318 8.1 t70 64.02 14.24 8.32 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -170.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -147.79 -7.15 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -132.72 103.02 5.9 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 121.166 1.803 . . . . 0.0 108.446 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 20.0 mt -80.21 153.87 28.29 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.654 0.781 . . . . 0.0 110.94 174.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.47 110.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -152.94 118.01 5.15 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.575 0.703 . . . . 0.0 110.355 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.9 t -93.77 120.23 33.76 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.809 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -83.54 -91.83 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 118.501 -0.761 . . . . 0.0 109.498 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.52 77.43 1.1 Allowed 'General case' 0 CA--C 1.555 1.166 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 52.63 46.55 26.51 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -166.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.6 mt -134.92 94.01 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -75.92 101.43 5.18 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.377 0.671 . . . . 0.0 109.854 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 61.1 m -112.0 104.71 12.99 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.545 -168.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.4 m -89.3 156.07 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.627 169.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.4 m -136.73 85.33 2.13 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -98.87 119.8 38.24 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -87.14 112.54 22.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -109.22 75.51 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.07 -89.0 1.36 Allowed Glycine 0 N--CA 1.484 1.867 0 C-N-CA 123.094 0.378 . . . . 0.0 113.157 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.67 -45.15 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 123.709 0.803 . . . . 0.0 111.831 164.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.3 mp -77.63 111.82 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.082 0.953 . . . . 0.0 109.082 -168.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -90.0 115.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 C-N-CA 123.891 0.876 . . . . 0.0 108.68 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.3 m -102.02 104.46 15.12 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -107.41 103.41 12.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.2 m -108.02 106.61 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -168.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 81.8 mtp -104.04 110.32 22.45 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -112.73 108.61 17.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 tp -68.3 -58.23 4.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.707 0.803 . . . . 0.0 112.346 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -155.86 -80.71 0.03 OUTLIER Glycine 0 N--CA 1.477 1.42 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -82.64 -31.34 28.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.6 mt -85.53 120.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 119.648 1.113 . . . . 0.0 108.104 -170.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.01 98.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -89.84 98.75 11.95 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.342 0.657 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -104.45 114.25 28.36 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -93.34 107.41 19.24 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -90.01 108.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.1 m -123.93 110.69 15.13 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 122.909 0.484 . . . . 0.0 110.102 -168.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -79.29 139.23 37.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.199 0.6 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.06 116.57 12.62 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.398 0.679 . . . . 0.0 110.907 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.485 . . . . . . . . 0 0 . 1 stop_ save_